https://www.hirudotherapysociety.org/en/research/thrombotic-risk-hepatitis-c-interplay-between-hepatic-zoherym-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/thrombotic-risk-hepatitis-c-interplay-between-hepatic-zoherym-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/thrombotic-risk-hepatitis-c-interplay-between-hepatic-zoherym-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/thrombotic-risk-hepatitis-c-interplay-between-hepatic-zoherym-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/postoperative-venous-thromboembolism-following-cesarean-delivery-prevalence-federspieljj-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/postoperative-venous-thromboembolism-following-cesarean-delivery-prevalence-federspieljj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/postoperative-venous-thromboembolism-following-cesarean-delivery-prevalence-federspieljj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/postoperative-venous-thromboembolism-following-cesarean-delivery-prevalence-federspieljj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/reduced-standard-dose-apixaban-secondary-prevention-cancer-associated-malhotrav-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/reduced-standard-dose-apixaban-secondary-prevention-cancer-associated-malhotrav-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/reduced-standard-dose-apixaban-secondary-prevention-cancer-associated-malhotrav-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/reduced-standard-dose-apixaban-secondary-prevention-cancer-associated-malhotrav-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/catheter-based-treatment-patients-acute-pulmonary-embolism-sonneholme-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/catheter-based-treatment-patients-acute-pulmonary-embolism-sonneholme-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/catheter-based-treatment-patients-acute-pulmonary-embolism-sonneholme-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/catheter-based-treatment-patients-acute-pulmonary-embolism-sonneholme-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/safety-efficacy-anti-coagulation-primary-secondary-venous-thromboembolism-rodriguezv-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/safety-efficacy-anti-coagulation-primary-secondary-venous-thromboembolism-rodriguezv-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/safety-efficacy-anti-coagulation-primary-secondary-venous-thromboembolism-rodriguezv-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/safety-efficacy-anti-coagulation-primary-secondary-venous-thromboembolism-rodriguezv-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/external-validation-michigan-risk-score-predicting-peripherally-rabelosilvaer-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/external-validation-michigan-risk-score-predicting-peripherally-rabelosilvaer-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/external-validation-michigan-risk-score-predicting-peripherally-rabelosilvaer-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/external-validation-michigan-risk-score-predicting-peripherally-rabelosilvaer-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/etiology-outcomes-upper-extremity-venous-thrombosis-retrospective-cox15fkuns-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/etiology-outcomes-upper-extremity-venous-thrombosis-retrospective-cox15fkuns-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/etiology-outcomes-upper-extremity-venous-thrombosis-retrospective-cox15fkuns-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/etiology-outcomes-upper-extremity-venous-thrombosis-retrospective-cox15fkuns-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/complications-port-a-cath-systems-institutional-romanian-oncological-patients-nemex219a-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/complications-port-a-cath-systems-institutional-romanian-oncological-patients-nemex219a-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/complications-port-a-cath-systems-institutional-romanian-oncological-patients-nemex219a-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/complications-port-a-cath-systems-institutional-romanian-oncological-patients-nemex219a-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prevention-treatment-thrombosis-patients-decompensated-cirrhosis-bellc-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prevention-treatment-thrombosis-patients-decompensated-cirrhosis-bellc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prevention-treatment-thrombosis-patients-decompensated-cirrhosis-bellc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prevention-treatment-thrombosis-patients-decompensated-cirrhosis-bellc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/rationalizing-thrombophilia-screening-children-insights-2019-retrospective-leleum-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/rationalizing-thrombophilia-screening-children-insights-2019-retrospective-leleum-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/rationalizing-thrombophilia-screening-children-insights-2019-retrospective-leleum-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/rationalizing-thrombophilia-screening-children-insights-2019-retrospective-leleum-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparison-activated-4-factor-prothrombin-complex-concentrates-reversal-crawleyrm-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparison-activated-4-factor-prothrombin-complex-concentrates-reversal-crawleyrm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparison-activated-4-factor-prothrombin-complex-concentrates-reversal-crawleyrm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparison-activated-4-factor-prothrombin-complex-concentrates-reversal-crawleyrm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/effectiveness-safety-aspirin-other-antithrombotics-vte-total-zhuyf-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/effectiveness-safety-aspirin-other-antithrombotics-vte-total-zhuyf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/effectiveness-safety-aspirin-other-antithrombotics-vte-total-zhuyf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/effectiveness-safety-aspirin-other-antithrombotics-vte-total-zhuyf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/recurrent-device-related-thrombosis-left-atrial-appendage-closure-jiaoy-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/recurrent-device-related-thrombosis-left-atrial-appendage-closure-jiaoy-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/recurrent-device-related-thrombosis-left-atrial-appendage-closure-jiaoy-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/recurrent-device-related-thrombosis-left-atrial-appendage-closure-jiaoy-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/development-preliminary-validation-picc-related-venous-thrombosis-risk-zhangj-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/development-preliminary-validation-picc-related-venous-thrombosis-risk-zhangj-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/development-preliminary-validation-picc-related-venous-thrombosis-risk-zhangj-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/development-preliminary-validation-picc-related-venous-thrombosis-risk-zhangj-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prothrombin-complex-concentrate-reversal-factor-xa-inhibitor-associated-shamieam-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prothrombin-complex-concentrate-reversal-factor-xa-inhibitor-associated-shamieam-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prothrombin-complex-concentrate-reversal-factor-xa-inhibitor-associated-shamieam-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prothrombin-complex-concentrate-reversal-factor-xa-inhibitor-associated-shamieam-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/how-determine-optimal-duration-anticoagulation-vte-evidence-based-djulbegovicb-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/how-determine-optimal-duration-anticoagulation-vte-evidence-based-djulbegovicb-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/how-determine-optimal-duration-anticoagulation-vte-evidence-based-djulbegovicb-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/how-determine-optimal-duration-anticoagulation-vte-evidence-based-djulbegovicb-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/influence-thrombophilia-low-molecular-weight-heparin-d-dimer-frenzele-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/influence-thrombophilia-low-molecular-weight-heparin-d-dimer-frenzele-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/influence-thrombophilia-low-molecular-weight-heparin-d-dimer-frenzele-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/influence-thrombophilia-low-molecular-weight-heparin-d-dimer-frenzele-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparison-three-risk-assessment-models-picc-related-thrombosis-huangc-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparison-three-risk-assessment-models-picc-related-thrombosis-huangc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparison-three-risk-assessment-models-picc-related-thrombosis-huangc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparison-three-risk-assessment-models-picc-related-thrombosis-huangc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparing-survival-vitamin-k-antagonists-low-molecular-weight-heparin-xirouv-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparing-survival-vitamin-k-antagonists-low-molecular-weight-heparin-xirouv-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparing-survival-vitamin-k-antagonists-low-molecular-weight-heparin-xirouv-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparing-survival-vitamin-k-antagonists-low-molecular-weight-heparin-xirouv-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-prophylaxis-obstetric-patients-orthopedic-injury-fischerl-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-prophylaxis-obstetric-patients-orthopedic-injury-fischerl-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-prophylaxis-obstetric-patients-orthopedic-injury-fischerl-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-prophylaxis-obstetric-patients-orthopedic-injury-fischerl-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/successful-catheter-directed-thrombolysis-patient-intermediate-high-risk-pulmonary-embolism-motazedianm-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/successful-catheter-directed-thrombolysis-patient-intermediate-high-risk-pulmonary-embolism-motazedianm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/successful-catheter-directed-thrombolysis-patient-intermediate-high-risk-pulmonary-embolism-motazedianm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/successful-catheter-directed-thrombolysis-patient-intermediate-high-risk-pulmonary-embolism-motazedianm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-oral-anticoagulants-portal-vein-thrombosis-cirrhosis-alnaamanikm-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-oral-anticoagulants-portal-vein-thrombosis-cirrhosis-alnaamanikm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-oral-anticoagulants-portal-vein-thrombosis-cirrhosis-alnaamanikm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-oral-anticoagulants-portal-vein-thrombosis-cirrhosis-alnaamanikm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/high-dose-postpartum-thromboprophylaxis-women-high-risk-pregnancy-related-rivrudscs-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/high-dose-postpartum-thromboprophylaxis-women-high-risk-pregnancy-related-rivrudscs-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/high-dose-postpartum-thromboprophylaxis-women-high-risk-pregnancy-related-rivrudscs-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/high-dose-postpartum-thromboprophylaxis-women-high-risk-pregnancy-related-rivrudscs-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/interpretable-machine-learning-risk-prediction-unplanned-extubation-among-yangy-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/interpretable-machine-learning-risk-prediction-unplanned-extubation-among-yangy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/interpretable-machine-learning-risk-prediction-unplanned-extubation-among-yangy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/interpretable-machine-learning-risk-prediction-unplanned-extubation-among-yangy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/apixaban-vitamin-k-antagonists-patients-antiphospholipid-syndrome-sikorskam-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/apixaban-vitamin-k-antagonists-patients-antiphospholipid-syndrome-sikorskam-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/apixaban-vitamin-k-antagonists-patients-antiphospholipid-syndrome-sikorskam-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/apixaban-vitamin-k-antagonists-patients-antiphospholipid-syndrome-sikorskam-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/priorities-clinical-research-pediatric-extracorporeal-membrane-oxygenation-muszynskija-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/priorities-clinical-research-pediatric-extracorporeal-membrane-oxygenation-muszynskija-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/priorities-clinical-research-pediatric-extracorporeal-membrane-oxygenation-muszynskija-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/priorities-clinical-research-pediatric-extracorporeal-membrane-oxygenation-muszynskija-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficacy-aspirin-preventing-venous-thromboembolism-total-knee-camposfloresd-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficacy-aspirin-preventing-venous-thromboembolism-total-knee-camposfloresd-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficacy-aspirin-preventing-venous-thromboembolism-total-knee-camposfloresd-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficacy-aspirin-preventing-venous-thromboembolism-total-knee-camposfloresd-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparison-4-factor-fixed-dose-4-factor-weight-based-dose-prothrombin-complex-alrashedm-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparison-4-factor-fixed-dose-4-factor-weight-based-dose-prothrombin-complex-alrashedm-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparison-4-factor-fixed-dose-4-factor-weight-based-dose-prothrombin-complex-alrashedm-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparison-4-factor-fixed-dose-4-factor-weight-based-dose-prothrombin-complex-alrashedm-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-factor-xa-inhibitors-low-molecular-weight-salazarca-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-factor-xa-inhibitors-low-molecular-weight-salazarca-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-factor-xa-inhibitors-low-molecular-weight-salazarca-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-factor-xa-inhibitors-low-molecular-weight-salazarca-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/conko-011-aio-sup-0115-ass-rivaroxaban-compared-low-molecular-sinnm-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/conko-011-aio-sup-0115-ass-rivaroxaban-compared-low-molecular-sinnm-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/conko-011-aio-sup-0115-ass-rivaroxaban-compared-low-molecular-sinnm-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/conko-011-aio-sup-0115-ass-rivaroxaban-compared-low-molecular-sinnm-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/doac-score-predicting-clinical-outcomes-left-atrial-asamim-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/doac-score-predicting-clinical-outcomes-left-atrial-asamim-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/doac-score-predicting-clinical-outcomes-left-atrial-asamim-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/doac-score-predicting-clinical-outcomes-left-atrial-asamim-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bleeding-risk-score-specifically-developed-direct-oral-piccolim-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bleeding-risk-score-specifically-developed-direct-oral-piccolim-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bleeding-risk-score-specifically-developed-direct-oral-piccolim-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bleeding-risk-score-specifically-developed-direct-oral-piccolim-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-oral-anticoagulants-patients-upper-extremity-deep-zyadaa-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-oral-anticoagulants-patients-upper-extremity-deep-zyadaa-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-oral-anticoagulants-patients-upper-extremity-deep-zyadaa-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-oral-anticoagulants-patients-upper-extremity-deep-zyadaa-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/left-atrial-appendage-occlusion-procedure-antithrombotics-less-kimmr-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/left-atrial-appendage-occlusion-procedure-antithrombotics-less-kimmr-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/left-atrial-appendage-occlusion-procedure-antithrombotics-less-kimmr-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/left-atrial-appendage-occlusion-procedure-antithrombotics-less-kimmr-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparing-mechanical-thrombectomy-catheter-directed-thrombolysis-pulmonary-afridia-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparing-mechanical-thrombectomy-catheter-directed-thrombolysis-pulmonary-afridia-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparing-mechanical-thrombectomy-catheter-directed-thrombolysis-pulmonary-afridia-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparing-mechanical-thrombectomy-catheter-directed-thrombolysis-pulmonary-afridia-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/effects-mortality-extended-short-term-anticoagulation-venous-thromboembolism-lefebvrem-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/effects-mortality-extended-short-term-anticoagulation-venous-thromboembolism-lefebvrem-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/effects-mortality-extended-short-term-anticoagulation-venous-thromboembolism-lefebvrem-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/effects-mortality-extended-short-term-anticoagulation-venous-thromboembolism-lefebvrem-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/effect-pcsk9-inhibition-alirocumab-patients-probable-familial-gebagp-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/effect-pcsk9-inhibition-alirocumab-patients-probable-familial-gebagp-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/effect-pcsk9-inhibition-alirocumab-patients-probable-familial-gebagp-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/effect-pcsk9-inhibition-alirocumab-patients-probable-familial-gebagp-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/long-term-efficacy-safety-direct-oral-anticoagulants-venous-pastorid-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/long-term-efficacy-safety-direct-oral-anticoagulants-venous-pastorid-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/long-term-efficacy-safety-direct-oral-anticoagulants-venous-pastorid-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/long-term-efficacy-safety-direct-oral-anticoagulants-venous-pastorid-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/impact-noacs-vkas-absolute-relative-cognitive-function-ferrantellis-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/impact-noacs-vkas-absolute-relative-cognitive-function-ferrantellis-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/impact-noacs-vkas-absolute-relative-cognitive-function-ferrantellis-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/impact-noacs-vkas-absolute-relative-cognitive-function-ferrantellis-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/intermittent-flow-clamp-flash-method-assess-readiness-nealjr-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/intermittent-flow-clamp-flash-method-assess-readiness-nealjr-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/intermittent-flow-clamp-flash-method-assess-readiness-nealjr-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/intermittent-flow-clamp-flash-method-assess-readiness-nealjr-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-acute-intermediate-risk-pulmonary-embolism-where-do-suncs-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-acute-intermediate-risk-pulmonary-embolism-where-do-suncs-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-acute-intermediate-risk-pulmonary-embolism-where-do-suncs-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-acute-intermediate-risk-pulmonary-embolism-where-do-suncs-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/position-statement-polish-society-gastroenterology-andexanet-alfa-adrychk-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/position-statement-polish-society-gastroenterology-andexanet-alfa-adrychk-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/position-statement-polish-society-gastroenterology-andexanet-alfa-adrychk-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/position-statement-polish-society-gastroenterology-andexanet-alfa-adrychk-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/andexxa-arc-urgency-uncertainty-unapproval-raylc-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/andexxa-arc-urgency-uncertainty-unapproval-raylc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/andexxa-arc-urgency-uncertainty-unapproval-raylc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/andexxa-arc-urgency-uncertainty-unapproval-raylc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficacy-safety-doacs-treatment-superficial-vein-thrombosis-boccatondaa-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficacy-safety-doacs-treatment-superficial-vein-thrombosis-boccatondaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficacy-safety-doacs-treatment-superficial-vein-thrombosis-boccatondaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficacy-safety-doacs-treatment-superficial-vein-thrombosis-boccatondaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/impact-catheter-directed-thrombolysis-socio-economic-burden-pulmonary-embolism-mohrk-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/impact-catheter-directed-thrombolysis-socio-economic-burden-pulmonary-embolism-mohrk-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/impact-catheter-directed-thrombolysis-socio-economic-burden-pulmonary-embolism-mohrk-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/impact-catheter-directed-thrombolysis-socio-economic-burden-pulmonary-embolism-mohrk-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/assessment-clinical-probability-scores-pulmonary-embolism-diagnosis-collangef-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/assessment-clinical-probability-scores-pulmonary-embolism-diagnosis-collangef-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/assessment-clinical-probability-scores-pulmonary-embolism-diagnosis-collangef-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/assessment-clinical-probability-scores-pulmonary-embolism-diagnosis-collangef-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/real-world-comparison-mechanical-thrombectomy-catheter-directed-thrombolysis-treatment-demareei-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/real-world-comparison-mechanical-thrombectomy-catheter-directed-thrombolysis-treatment-demareei-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/real-world-comparison-mechanical-thrombectomy-catheter-directed-thrombolysis-treatment-demareei-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/real-world-comparison-mechanical-thrombectomy-catheter-directed-thrombolysis-treatment-demareei-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/percutaneous-reperfusion-therapies-anticoagulation-patients-acute-intermediate-high-risk-ivanauskienx117t-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/percutaneous-reperfusion-therapies-anticoagulation-patients-acute-intermediate-high-risk-ivanauskienx117t-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/percutaneous-reperfusion-therapies-anticoagulation-patients-acute-intermediate-high-risk-ivanauskienx117t-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/percutaneous-reperfusion-therapies-anticoagulation-patients-acute-intermediate-high-risk-ivanauskienx117t-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficacy-safety-regional-citrate-anticoagulation-neurocritical-care-zhugz-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficacy-safety-regional-citrate-anticoagulation-neurocritical-care-zhugz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficacy-safety-regional-citrate-anticoagulation-neurocritical-care-zhugz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficacy-safety-regional-citrate-anticoagulation-neurocritical-care-zhugz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/early-catheter-directed-portal-vein-thrombolysis-myeloproliferative-disorder-related-chiuyc-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/early-catheter-directed-portal-vein-thrombolysis-myeloproliferative-disorder-related-chiuyc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/early-catheter-directed-portal-vein-thrombolysis-myeloproliferative-disorder-related-chiuyc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/early-catheter-directed-portal-vein-thrombolysis-myeloproliferative-disorder-related-chiuyc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/reperfusion-strategies-acute-pulmonary-embolism-design-rationale-farmakisit-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/reperfusion-strategies-acute-pulmonary-embolism-design-rationale-farmakisit-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/reperfusion-strategies-acute-pulmonary-embolism-design-rationale-farmakisit-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/reperfusion-strategies-acute-pulmonary-embolism-design-rationale-farmakisit-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/missing-data-missed-risks-complications-documentation-gaps-voigtm-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/missing-data-missed-risks-complications-documentation-gaps-voigtm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/missing-data-missed-risks-complications-documentation-gaps-voigtm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/missing-data-missed-risks-complications-documentation-gaps-voigtm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/impact-enoxaparin-hemoglobin-platelet-parameters-post-cesarean-venous-dagdevirene-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/impact-enoxaparin-hemoglobin-platelet-parameters-post-cesarean-venous-dagdevirene-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/impact-enoxaparin-hemoglobin-platelet-parameters-post-cesarean-venous-dagdevirene-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/impact-enoxaparin-hemoglobin-platelet-parameters-post-cesarean-venous-dagdevirene-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/disproportionality-fondaparinux-associated-adverse-events-fda-adverse-kangf-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/disproportionality-fondaparinux-associated-adverse-events-fda-adverse-kangf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/disproportionality-fondaparinux-associated-adverse-events-fda-adverse-kangf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/disproportionality-fondaparinux-associated-adverse-events-fda-adverse-kangf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/successful-liver-transplantation-endovascular-recanalization-chronic-portal-x15ealo-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/successful-liver-transplantation-endovascular-recanalization-chronic-portal-x15ealo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/successful-liver-transplantation-endovascular-recanalization-chronic-portal-x15ealo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/successful-liver-transplantation-endovascular-recanalization-chronic-portal-x15ealo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prevalence-bone-mineral-disease-children-acute-kidney-rairikarmv-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prevalence-bone-mineral-disease-children-acute-kidney-rairikarmv-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prevalence-bone-mineral-disease-children-acute-kidney-rairikarmv-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prevalence-bone-mineral-disease-children-acute-kidney-rairikarmv-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/complexities-pediatric-tuberculosis-case-advanced-disease-complicated-bogalea-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/complexities-pediatric-tuberculosis-case-advanced-disease-complicated-bogalea-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/complexities-pediatric-tuberculosis-case-advanced-disease-complicated-bogalea-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/complexities-pediatric-tuberculosis-case-advanced-disease-complicated-bogalea-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prothrombin-complex-concentrate-oral-factor-xa-inhibitor-associated-shamieam-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prothrombin-complex-concentrate-oral-factor-xa-inhibitor-associated-shamieam-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prothrombin-complex-concentrate-oral-factor-xa-inhibitor-associated-shamieam-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prothrombin-complex-concentrate-oral-factor-xa-inhibitor-associated-shamieam-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hereditary-antithrombin-deficiency-pediatric-patients-pathophysiology-clinical-rodgersgm-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hereditary-antithrombin-deficiency-pediatric-patients-pathophysiology-clinical-rodgersgm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hereditary-antithrombin-deficiency-pediatric-patients-pathophysiology-clinical-rodgersgm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hereditary-antithrombin-deficiency-pediatric-patients-pathophysiology-clinical-rodgersgm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/complications-patients-cancer-associated-thrombosis-tinzaparin-cancer-site-mahxe9i-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/complications-patients-cancer-associated-thrombosis-tinzaparin-cancer-site-mahxe9i-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/complications-patients-cancer-associated-thrombosis-tinzaparin-cancer-site-mahxe9i-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/complications-patients-cancer-associated-thrombosis-tinzaparin-cancer-site-mahxe9i-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/citrate-bivalirudin-anticoagulation-continuous-renal-replacement-therapy-yadavad-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/citrate-bivalirudin-anticoagulation-continuous-renal-replacement-therapy-yadavad-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/citrate-bivalirudin-anticoagulation-continuous-renal-replacement-therapy-yadavad-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/citrate-bivalirudin-anticoagulation-continuous-renal-replacement-therapy-yadavad-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/coagulation-disorders-thromboprophylaxis-pancreatic-cancer-review-current-grochowskaa-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/coagulation-disorders-thromboprophylaxis-pancreatic-cancer-review-current-grochowskaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/coagulation-disorders-thromboprophylaxis-pancreatic-cancer-review-current-grochowskaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/coagulation-disorders-thromboprophylaxis-pancreatic-cancer-review-current-grochowskaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/reduced-extended-dose-anticoagulation-venous-thromboembolism-patients-without-alimf-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/reduced-extended-dose-anticoagulation-venous-thromboembolism-patients-without-alimf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/reduced-extended-dose-anticoagulation-venous-thromboembolism-patients-without-alimf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/reduced-extended-dose-anticoagulation-venous-thromboembolism-patients-without-alimf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/safety-effectiveness-nafamostat-mesylate-continuous-renal-replacement-cheny-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/safety-effectiveness-nafamostat-mesylate-continuous-renal-replacement-cheny-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/safety-effectiveness-nafamostat-mesylate-continuous-renal-replacement-cheny-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/safety-effectiveness-nafamostat-mesylate-continuous-renal-replacement-cheny-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/antepartum-postpartum-thromboprophylaxis-preferences-insights-single-center-survey-rabaliz-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/antepartum-postpartum-thromboprophylaxis-preferences-insights-single-center-survey-rabaliz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/antepartum-postpartum-thromboprophylaxis-preferences-insights-single-center-survey-rabaliz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/antepartum-postpartum-thromboprophylaxis-preferences-insights-single-center-survey-rabaliz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/mechanical-thrombectomy-catheter-directed-thrombolysis-acute-pulmonary-embolism-kimjm-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/mechanical-thrombectomy-catheter-directed-thrombolysis-acute-pulmonary-embolism-kimjm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/mechanical-thrombectomy-catheter-directed-thrombolysis-acute-pulmonary-embolism-kimjm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/mechanical-thrombectomy-catheter-directed-thrombolysis-acute-pulmonary-embolism-kimjm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/sequential-anticoagulation-lmwh-doacs-cirrhotic-portal-vein-onaym-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/sequential-anticoagulation-lmwh-doacs-cirrhotic-portal-vein-onaym-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/sequential-anticoagulation-lmwh-doacs-cirrhotic-portal-vein-onaym-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/sequential-anticoagulation-lmwh-doacs-cirrhotic-portal-vein-onaym-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/andexanet-xa0-alfa-reduces-hematoma-expansion-following-lieschkef-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/andexanet-xa0-alfa-reduces-hematoma-expansion-following-lieschkef-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/andexanet-xa0-alfa-reduces-hematoma-expansion-following-lieschkef-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/andexanet-xa0-alfa-reduces-hematoma-expansion-following-lieschkef-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/evaluation-clinical-performance-risk-scoring-model-venous-kongcw-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/evaluation-clinical-performance-risk-scoring-model-venous-kongcw-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/evaluation-clinical-performance-risk-scoring-model-venous-kongcw-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/evaluation-clinical-performance-risk-scoring-model-venous-kongcw-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/regional-citrate-anticoagulation-prolongs-filter-lifespan-improves-jinw-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/regional-citrate-anticoagulation-prolongs-filter-lifespan-improves-jinw-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/regional-citrate-anticoagulation-prolongs-filter-lifespan-improves-jinw-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/regional-citrate-anticoagulation-prolongs-filter-lifespan-improves-jinw-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/real-world-experience-direct-oral-anticoagulant-doac-brownca-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/real-world-experience-direct-oral-anticoagulant-doac-brownca-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/real-world-experience-direct-oral-anticoagulant-doac-brownca-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/real-world-experience-direct-oral-anticoagulant-doac-brownca-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/circuit-survival-children-hemolytic-uremic-syndrome-requiring-villadav-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/circuit-survival-children-hemolytic-uremic-syndrome-requiring-villadav-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/circuit-survival-children-hemolytic-uremic-syndrome-requiring-villadav-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/circuit-survival-children-hemolytic-uremic-syndrome-requiring-villadav-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/risk-factors-tivad-related-venous-thrombosis-chinese-breast-liy-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/risk-factors-tivad-related-venous-thrombosis-chinese-breast-liy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/risk-factors-tivad-related-venous-thrombosis-chinese-breast-liy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/risk-factors-tivad-related-venous-thrombosis-chinese-breast-liy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/excessive-apixaban-concentrations-bleeding-patient-treated-pharmacological-krausrf-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/excessive-apixaban-concentrations-bleeding-patient-treated-pharmacological-krausrf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/excessive-apixaban-concentrations-bleeding-patient-treated-pharmacological-krausrf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/excessive-apixaban-concentrations-bleeding-patient-treated-pharmacological-krausrf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/extended-maintenance-intervals-implanted-venous-ports-oncology-pinacabralt-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/extended-maintenance-intervals-implanted-venous-ports-oncology-pinacabralt-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/extended-maintenance-intervals-implanted-venous-ports-oncology-pinacabralt-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/extended-maintenance-intervals-implanted-venous-ports-oncology-pinacabralt-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/predictive-model-picc-related-thrombosis-sepsis-patients-xgboost-haow-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/predictive-model-picc-related-thrombosis-sepsis-patients-xgboost-haow-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/predictive-model-picc-related-thrombosis-sepsis-patients-xgboost-haow-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/predictive-model-picc-related-thrombosis-sepsis-patients-xgboost-haow-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/non-cirrhotic-portal-splenic-mesenteric-vein-thrombosis-unmasking-jak2-v617f-positive-otaket-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/non-cirrhotic-portal-splenic-mesenteric-vein-thrombosis-unmasking-jak2-v617f-positive-otaket-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/non-cirrhotic-portal-splenic-mesenteric-vein-thrombosis-unmasking-jak2-v617f-positive-otaket-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/non-cirrhotic-portal-splenic-mesenteric-vein-thrombosis-unmasking-jak2-v617f-positive-otaket-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/impact-treatment-response-anticoagulant-therapy-liver-related-events-maedaa-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/impact-treatment-response-anticoagulant-therapy-liver-related-events-maedaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/impact-treatment-response-anticoagulant-therapy-liver-related-events-maedaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/impact-treatment-response-anticoagulant-therapy-liver-related-events-maedaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cerebral-venous-thrombosis-pregnancy-johnnm-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cerebral-venous-thrombosis-pregnancy-johnnm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cerebral-venous-thrombosis-pregnancy-johnnm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cerebral-venous-thrombosis-pregnancy-johnnm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/machine-learning-models-predicting-bleeding-risk-anticoagulated-teowzy-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/machine-learning-models-predicting-bleeding-risk-anticoagulated-teowzy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/machine-learning-models-predicting-bleeding-risk-anticoagulated-teowzy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/machine-learning-models-predicting-bleeding-risk-anticoagulated-teowzy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/machine-learning-survival-model-personalised-prevention-catheter-related-geh-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/machine-learning-survival-model-personalised-prevention-catheter-related-geh-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/machine-learning-survival-model-personalised-prevention-catheter-related-geh-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/machine-learning-survival-model-personalised-prevention-catheter-related-geh-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/central-line-associated-thrombosis-infections-patients-acute-leukemias-alsulimant-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/central-line-associated-thrombosis-infections-patients-acute-leukemias-alsulimant-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/central-line-associated-thrombosis-infections-patients-acute-leukemias-alsulimant-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/central-line-associated-thrombosis-infections-patients-acute-leukemias-alsulimant-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/survival-assessment-warfarin-international-normalized-ratio-exposure-ryuj-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/survival-assessment-warfarin-international-normalized-ratio-exposure-ryuj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/survival-assessment-warfarin-international-normalized-ratio-exposure-ryuj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/survival-assessment-warfarin-international-normalized-ratio-exposure-ryuj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-oral-anticoagulants-portal-vein-thrombosis-cirrhotic-boccatondaa-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-oral-anticoagulants-portal-vein-thrombosis-cirrhotic-boccatondaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-oral-anticoagulants-portal-vein-thrombosis-cirrhotic-boccatondaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-oral-anticoagulants-portal-vein-thrombosis-cirrhotic-boccatondaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/chinese-clinical-practice-guideline-prescription-fluids-application-x-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/chinese-clinical-practice-guideline-prescription-fluids-application-x-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/chinese-clinical-practice-guideline-prescription-fluids-application-x-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/chinese-clinical-practice-guideline-prescription-fluids-application-x-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/citrate-doubles-crrt-filter-lifespan-real-world-chinese-ouq-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/citrate-doubles-crrt-filter-lifespan-real-world-chinese-ouq-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/citrate-doubles-crrt-filter-lifespan-real-world-chinese-ouq-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/citrate-doubles-crrt-filter-lifespan-real-world-chinese-ouq-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prefilled-infused-regional-citrate-anticoagulation-continuous-renal-zouh-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prefilled-infused-regional-citrate-anticoagulation-continuous-renal-zouh-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prefilled-infused-regional-citrate-anticoagulation-continuous-renal-zouh-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prefilled-infused-regional-citrate-anticoagulation-continuous-renal-zouh-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/intraoperative-heparin-resistance-internal-carotid-artery-occlusion-kawamuras-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/intraoperative-heparin-resistance-internal-carotid-artery-occlusion-kawamuras-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/intraoperative-heparin-resistance-internal-carotid-artery-occlusion-kawamuras-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/intraoperative-heparin-resistance-internal-carotid-artery-occlusion-kawamuras-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/diplopia-papilledema-secondary-thrombosis-longitudinal-venous-sinus-dalmaweiszhauszj-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/diplopia-papilledema-secondary-thrombosis-longitudinal-venous-sinus-dalmaweiszhauszj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/diplopia-papilledema-secondary-thrombosis-longitudinal-venous-sinus-dalmaweiszhauszj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/diplopia-papilledema-secondary-thrombosis-longitudinal-venous-sinus-dalmaweiszhauszj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/appropriateness-oral-anticoagulant-therapy-associated-factors-among-hailesilasegg-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/appropriateness-oral-anticoagulant-therapy-associated-factors-among-hailesilasegg-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/appropriateness-oral-anticoagulant-therapy-associated-factors-among-hailesilasegg-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/appropriateness-oral-anticoagulant-therapy-associated-factors-among-hailesilasegg-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/implementation-quality-modifiable-determinant-filter-lifespan-regional-ouq-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/implementation-quality-modifiable-determinant-filter-lifespan-regional-ouq-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/implementation-quality-modifiable-determinant-filter-lifespan-regional-ouq-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/implementation-quality-modifiable-determinant-filter-lifespan-regional-ouq-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/inherited-thrombophilia-republic-georgia-women-without-personal-kartvelishvilik-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/inherited-thrombophilia-republic-georgia-women-without-personal-kartvelishvilik-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/inherited-thrombophilia-republic-georgia-women-without-personal-kartvelishvilik-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/inherited-thrombophilia-republic-georgia-women-without-personal-kartvelishvilik-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-challenges-cancer-patients-prevention-detection-treatment-chiusolos-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-challenges-cancer-patients-prevention-detection-treatment-chiusolos-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-challenges-cancer-patients-prevention-detection-treatment-chiusolos-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-challenges-cancer-patients-prevention-detection-treatment-chiusolos-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/early-venous-thrombus-resolution-neonates-infants-retrospective-yane-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/early-venous-thrombus-resolution-neonates-infants-retrospective-yane-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/early-venous-thrombus-resolution-neonates-infants-retrospective-yane-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/early-venous-thrombus-resolution-neonates-infants-retrospective-yane-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/continuous-intermittent-anticoagulation-endoscopic-treatment-esophageal-varices-hey-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/continuous-intermittent-anticoagulation-endoscopic-treatment-esophageal-varices-hey-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/continuous-intermittent-anticoagulation-endoscopic-treatment-esophageal-varices-hey-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/continuous-intermittent-anticoagulation-endoscopic-treatment-esophageal-varices-hey-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/doac-score-has-bled-orbit-predicting-bleeding-events-guoy-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/doac-score-has-bled-orbit-predicting-bleeding-events-guoy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/doac-score-has-bled-orbit-predicting-bleeding-events-guoy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/doac-score-has-bled-orbit-predicting-bleeding-events-guoy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/clinical-outcomes-following-catheter-related-venous-thrombo-embolism-among-pellandmarcottemc-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/clinical-outcomes-following-catheter-related-venous-thrombo-embolism-among-pellandmarcottemc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/clinical-outcomes-following-catheter-related-venous-thrombo-embolism-among-pellandmarcottemc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/clinical-outcomes-following-catheter-related-venous-thrombo-embolism-among-pellandmarcottemc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/multi-center-randomized-controlled-catheter-directed-mechanical-thrombectomy-systemic-wangc-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/multi-center-randomized-controlled-catheter-directed-mechanical-thrombectomy-systemic-wangc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/multi-center-randomized-controlled-catheter-directed-mechanical-thrombectomy-systemic-wangc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/multi-center-randomized-controlled-catheter-directed-mechanical-thrombectomy-systemic-wangc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficacy-safety-evaluation-thromboprophylaxis-strategies-central-venous-mengm-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficacy-safety-evaluation-thromboprophylaxis-strategies-central-venous-mengm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficacy-safety-evaluation-thromboprophylaxis-strategies-central-venous-mengm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficacy-safety-evaluation-thromboprophylaxis-strategies-central-venous-mengm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-oral-anticoagulantslmwh-cancer-associated-thrombosis-updated-asadd-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-oral-anticoagulantslmwh-cancer-associated-thrombosis-updated-asadd-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-oral-anticoagulantslmwh-cancer-associated-thrombosis-updated-asadd-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-oral-anticoagulantslmwh-cancer-associated-thrombosis-updated-asadd-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparative-catheter-to-vein-ratio-definitions-calculations-review-diameter-based-ahmedh-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparative-catheter-to-vein-ratio-definitions-calculations-review-diameter-based-ahmedh-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparative-catheter-to-vein-ratio-definitions-calculations-review-diameter-based-ahmedh-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparative-catheter-to-vein-ratio-definitions-calculations-review-diameter-based-ahmedh-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/arterial-venous-thrombotic-complications-following-recreational-nitrous-stephand-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/arterial-venous-thrombotic-complications-following-recreational-nitrous-stephand-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/arterial-venous-thrombotic-complications-following-recreational-nitrous-stephand-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/arterial-venous-thrombotic-complications-following-recreational-nitrous-stephand-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-pregnancy-pathophysiology-diagnostic-algorithms-therapeutic-sugraliyeva-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-pregnancy-pathophysiology-diagnostic-algorithms-therapeutic-sugraliyeva-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-pregnancy-pathophysiology-diagnostic-algorithms-therapeutic-sugraliyeva-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-pregnancy-pathophysiology-diagnostic-algorithms-therapeutic-sugraliyeva-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/renal-replacement-therapy-patients-under-extracorporeal-membrane-tomovicf-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/renal-replacement-therapy-patients-under-extracorporeal-membrane-tomovicf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/renal-replacement-therapy-patients-under-extracorporeal-membrane-tomovicf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/renal-replacement-therapy-patients-under-extracorporeal-membrane-tomovicf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/emergency-reversal-rivaroxaban-andexanet-alfa-child-hemorrhagic-rafaeliana-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/emergency-reversal-rivaroxaban-andexanet-alfa-child-hemorrhagic-rafaeliana-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/emergency-reversal-rivaroxaban-andexanet-alfa-child-hemorrhagic-rafaeliana-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/emergency-reversal-rivaroxaban-andexanet-alfa-child-hemorrhagic-rafaeliana-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/peripherally-inserted-central-catheter-performance-oncology-patients-consolol-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/peripherally-inserted-central-catheter-performance-oncology-patients-consolol-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/peripherally-inserted-central-catheter-performance-oncology-patients-consolol-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/peripherally-inserted-central-catheter-performance-oncology-patients-consolol-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/outcomes-endovascular-treatment-medically-refractory-cerebral-venous-vermah-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/outcomes-endovascular-treatment-medically-refractory-cerebral-venous-vermah-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/outcomes-endovascular-treatment-medically-refractory-cerebral-venous-vermah-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/outcomes-endovascular-treatment-medically-refractory-cerebral-venous-vermah-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/regional-citrate-anticoagulation-renal-replacement-therapy-venovenous-gianim-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/regional-citrate-anticoagulation-renal-replacement-therapy-venovenous-gianim-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/regional-citrate-anticoagulation-renal-replacement-therapy-venovenous-gianim-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/regional-citrate-anticoagulation-renal-replacement-therapy-venovenous-gianim-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/andexanet-alfa-reversal-anticoagulation-dutch-practice-data-krommenhoekjf-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/andexanet-alfa-reversal-anticoagulation-dutch-practice-data-krommenhoekjf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/andexanet-alfa-reversal-anticoagulation-dutch-practice-data-krommenhoekjf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/andexanet-alfa-reversal-anticoagulation-dutch-practice-data-krommenhoekjf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cytosorb-haemoadsorption-critically-ill-children-multicentre-observational-bottarig-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cytosorb-haemoadsorption-critically-ill-children-multicentre-observational-bottarig-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cytosorb-haemoadsorption-critically-ill-children-multicentre-observational-bottarig-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cytosorb-haemoadsorption-critically-ill-children-multicentre-observational-bottarig-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/managing-coagulation-abnormalities-bleeding-thrombosis-patients-cirrhosis-tripodia-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/managing-coagulation-abnormalities-bleeding-thrombosis-patients-cirrhosis-tripodia-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/managing-coagulation-abnormalities-bleeding-thrombosis-patients-cirrhosis-tripodia-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/managing-coagulation-abnormalities-bleeding-thrombosis-patients-cirrhosis-tripodia-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/rare-pediatric-multi-system-thrombosis-post-covid-19-three-year-follow-up-zhus-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/rare-pediatric-multi-system-thrombosis-post-covid-19-three-year-follow-up-zhus-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/rare-pediatric-multi-system-thrombosis-post-covid-19-three-year-follow-up-zhus-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/rare-pediatric-multi-system-thrombosis-post-covid-19-three-year-follow-up-zhus-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/fondaparinux-treat-cerebral-venous-sinus-thrombosis-complicated-qim-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/fondaparinux-treat-cerebral-venous-sinus-thrombosis-complicated-qim-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/fondaparinux-treat-cerebral-venous-sinus-thrombosis-complicated-qim-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/fondaparinux-treat-cerebral-venous-sinus-thrombosis-complicated-qim-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-thrombosis-14-year-old-boy-combination-may-thurner-makeevv-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-thrombosis-14-year-old-boy-combination-may-thurner-makeevv-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-thrombosis-14-year-old-boy-combination-may-thurner-makeevv-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-thrombosis-14-year-old-boy-combination-may-thurner-makeevv-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/sinusitis-blindness-unusual-case-pott-s-puffy-jidalm-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/sinusitis-blindness-unusual-case-pott-s-puffy-jidalm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/sinusitis-blindness-unusual-case-pott-s-puffy-jidalm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/sinusitis-blindness-unusual-case-pott-s-puffy-jidalm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/metabolic-complications-citrate-anticoagulation-continuous-renal-replacement-jacobsr-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/metabolic-complications-citrate-anticoagulation-continuous-renal-replacement-jacobsr-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/metabolic-complications-citrate-anticoagulation-continuous-renal-replacement-jacobsr-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/metabolic-complications-citrate-anticoagulation-continuous-renal-replacement-jacobsr-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cerebral-venous-sinus-thrombosis-associated-testosterone-gender-affirming-rojasoviedojl-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cerebral-venous-sinus-thrombosis-associated-testosterone-gender-affirming-rojasoviedojl-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cerebral-venous-sinus-thrombosis-associated-testosterone-gender-affirming-rojasoviedojl-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cerebral-venous-sinus-thrombosis-associated-testosterone-gender-affirming-rojasoviedojl-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/paediatric-septic-thrombophlebitis-secondary-otogenic-infection-single-centre-nobachta-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/paediatric-septic-thrombophlebitis-secondary-otogenic-infection-single-centre-nobachta-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/paediatric-septic-thrombophlebitis-secondary-otogenic-infection-single-centre-nobachta-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/paediatric-septic-thrombophlebitis-secondary-otogenic-infection-single-centre-nobachta-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/catheter-related-superficial-venous-thrombosis-upper-extremity-narrative-siniscalchic-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/catheter-related-superficial-venous-thrombosis-upper-extremity-narrative-siniscalchic-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/catheter-related-superficial-venous-thrombosis-upper-extremity-narrative-siniscalchic-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/catheter-related-superficial-venous-thrombosis-upper-extremity-narrative-siniscalchic-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/otogenic-sigmoid-sinus-thrombosis-34-year-old-woman-rare-lauyfy-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/otogenic-sigmoid-sinus-thrombosis-34-year-old-woman-rare-lauyfy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/otogenic-sigmoid-sinus-thrombosis-34-year-old-woman-rare-lauyfy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/otogenic-sigmoid-sinus-thrombosis-34-year-old-woman-rare-lauyfy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cerebral-venous-sinus-thrombosis-secondary-nasopharyngeal-abscess-wuy-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cerebral-venous-sinus-thrombosis-secondary-nasopharyngeal-abscess-wuy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cerebral-venous-sinus-thrombosis-secondary-nasopharyngeal-abscess-wuy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cerebral-venous-sinus-thrombosis-secondary-nasopharyngeal-abscess-wuy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/correction-efficacy-safety-evaluation-thromboprophylaxis-strategies-central-mengm-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/correction-efficacy-safety-evaluation-thromboprophylaxis-strategies-central-mengm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/correction-efficacy-safety-evaluation-thromboprophylaxis-strategies-central-mengm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/correction-efficacy-safety-evaluation-thromboprophylaxis-strategies-central-mengm-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/contemporary-management-pediatric-venous-thrombosis-how-does-zabeidaa-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/contemporary-management-pediatric-venous-thrombosis-how-does-zabeidaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/contemporary-management-pediatric-venous-thrombosis-how-does-zabeidaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/contemporary-management-pediatric-venous-thrombosis-how-does-zabeidaa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/emerging-insights-management-venous-thromboembolism-patients-cancer-guanz-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/emerging-insights-management-venous-thromboembolism-patients-cancer-guanz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/emerging-insights-management-venous-thromboembolism-patients-cancer-guanz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/emerging-insights-management-venous-thromboembolism-patients-cancer-guanz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficacy-safety-18-mmol-l-sodium-citrate-zhaoph-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficacy-safety-18-mmol-l-sodium-citrate-zhaoph-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficacy-safety-18-mmol-l-sodium-citrate-zhaoph-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficacy-safety-18-mmol-l-sodium-citrate-zhaoph-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/ionized-hypocalcemia-prior-continuous-veno-venous-hemodialysis-initiation-thibaultb-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/ionized-hypocalcemia-prior-continuous-veno-venous-hemodialysis-initiation-thibaultb-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/ionized-hypocalcemia-prior-continuous-veno-venous-hemodialysis-initiation-thibaultb-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/ionized-hypocalcemia-prior-continuous-veno-venous-hemodialysis-initiation-thibaultb-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/extensive-cerebral-venous-thrombosis-associated-severe-hyperhomocysteinemia-hanl-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/extensive-cerebral-venous-thrombosis-associated-severe-hyperhomocysteinemia-hanl-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/extensive-cerebral-venous-thrombosis-associated-severe-hyperhomocysteinemia-hanl-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/extensive-cerebral-venous-thrombosis-associated-severe-hyperhomocysteinemia-hanl-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cerebral-venous-thrombosis-involving-vein-labb-xe9-berrocalc-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cerebral-venous-thrombosis-involving-vein-labb-xe9-berrocalc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cerebral-venous-thrombosis-involving-vein-labb-xe9-berrocalc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cerebral-venous-thrombosis-involving-vein-labb-xe9-berrocalc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/recurrent-pregnancy-loss-despite-therapeutic-anticoagulation-patient-linf-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/recurrent-pregnancy-loss-despite-therapeutic-anticoagulation-patient-linf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/recurrent-pregnancy-loss-despite-therapeutic-anticoagulation-patient-linf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/recurrent-pregnancy-loss-despite-therapeutic-anticoagulation-patient-linf-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/glue-embolus-induced-portosplenic-thrombosis-transjugular-intrahepatic-portosystemic-kotadiams-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/glue-embolus-induced-portosplenic-thrombosis-transjugular-intrahepatic-portosystemic-kotadiams-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/glue-embolus-induced-portosplenic-thrombosis-transjugular-intrahepatic-portosystemic-kotadiams-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/glue-embolus-induced-portosplenic-thrombosis-transjugular-intrahepatic-portosystemic-kotadiams-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/impact-severe-thrombocytopenia-safety-splenectomy-patients-cirrhosis-minh-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/impact-severe-thrombocytopenia-safety-splenectomy-patients-cirrhosis-minh-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/impact-severe-thrombocytopenia-safety-splenectomy-patients-cirrhosis-minh-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/impact-severe-thrombocytopenia-safety-splenectomy-patients-cirrhosis-minh-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparison-between-thrombophilic-gene-polymorphisms-among-high-levkovam-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparison-between-thrombophilic-gene-polymorphisms-among-high-levkovam-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparison-between-thrombophilic-gene-polymorphisms-among-high-levkovam-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparison-between-thrombophilic-gene-polymorphisms-among-high-levkovam-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/high-risk-thrombosis-recurrence-patients-homozygous-compound-federicieh-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/high-risk-thrombosis-recurrence-patients-homozygous-compound-federicieh-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/high-risk-thrombosis-recurrence-patients-homozygous-compound-federicieh-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/high-risk-thrombosis-recurrence-patients-homozygous-compound-federicieh-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/treatment-cancer-associated-thrombosis-beyond-hokusai-mahxe9i-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/treatment-cancer-associated-thrombosis-beyond-hokusai-mahxe9i-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/treatment-cancer-associated-thrombosis-beyond-hokusai-mahxe9i-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/treatment-cancer-associated-thrombosis-beyond-hokusai-mahxe9i-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/extending-venous-thromboembolism-secondary-prevention-apixaban-cancer-mcbanerd-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/extending-venous-thromboembolism-secondary-prevention-apixaban-cancer-mcbanerd-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/extending-venous-thromboembolism-secondary-prevention-apixaban-cancer-mcbanerd-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/extending-venous-thromboembolism-secondary-prevention-apixaban-cancer-mcbanerd-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/clinical-implications-incidental-venous-thromboembolism-cancer-patients-mulderfi-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/clinical-implications-incidental-venous-thromboembolism-cancer-patients-mulderfi-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/clinical-implications-incidental-venous-thromboembolism-cancer-patients-mulderfi-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/clinical-implications-incidental-venous-thromboembolism-cancer-patients-mulderfi-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/edoxaban-treatment-venous-thromboembolism-patient-groups-different-mulderfi-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/edoxaban-treatment-venous-thromboembolism-patient-groups-different-mulderfi-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/edoxaban-treatment-venous-thromboembolism-patient-groups-different-mulderfi-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/edoxaban-treatment-venous-thromboembolism-patient-groups-different-mulderfi-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-direct-thrombin-inhibitors-extracorporeal-membrane-oxygenation-bursteinb-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-direct-thrombin-inhibitors-extracorporeal-membrane-oxygenation-bursteinb-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-direct-thrombin-inhibitors-extracorporeal-membrane-oxygenation-bursteinb-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-direct-thrombin-inhibitors-extracorporeal-membrane-oxygenation-bursteinb-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/european-stroke-organisation-guideline-reversal-oral-anticoagulants-christensenh-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/european-stroke-organisation-guideline-reversal-oral-anticoagulants-christensenh-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/european-stroke-organisation-guideline-reversal-oral-anticoagulants-christensenh-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/european-stroke-organisation-guideline-reversal-oral-anticoagulants-christensenh-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/inherited-thrombophilia-lebanese-family-four-generations-case-khalifes-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/inherited-thrombophilia-lebanese-family-four-generations-case-khalifes-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/inherited-thrombophilia-lebanese-family-four-generations-case-khalifes-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/inherited-thrombophilia-lebanese-family-four-generations-case-khalifes-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/corrigendum-edoxaban-treatment-venous-thromboembolism-patient-groups-mulderfi-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/corrigendum-edoxaban-treatment-venous-thromboembolism-patient-groups-mulderfi-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/corrigendum-edoxaban-treatment-venous-thromboembolism-patient-groups-mulderfi-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/corrigendum-edoxaban-treatment-venous-thromboembolism-patient-groups-mulderfi-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/contemporary-meta-analysis-extended-direct-acting-oral-anticoagulant-thromboprophylaxis-bhallav-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/contemporary-meta-analysis-extended-direct-acting-oral-anticoagulant-thromboprophylaxis-bhallav-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/contemporary-meta-analysis-extended-direct-acting-oral-anticoagulant-thromboprophylaxis-bhallav-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/contemporary-meta-analysis-extended-direct-acting-oral-anticoagulant-thromboprophylaxis-bhallav-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/perioperative-management-anticoagulation-talarig-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/perioperative-management-anticoagulation-talarig-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/perioperative-management-anticoagulation-talarig-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/perioperative-management-anticoagulation-talarig-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/three-factorial-genetic-thrombophilia-recurrent-thrombotic-events-saudi-alsultanoa-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/three-factorial-genetic-thrombophilia-recurrent-thrombotic-events-saudi-alsultanoa-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/three-factorial-genetic-thrombophilia-recurrent-thrombotic-events-saudi-alsultanoa-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/three-factorial-genetic-thrombophilia-recurrent-thrombotic-events-saudi-alsultanoa-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/safety-efficacy-prothrombin-complex-concentrate-pcc-anticoagulation-faulknerh-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/safety-efficacy-prothrombin-complex-concentrate-pcc-anticoagulation-faulknerh-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/safety-efficacy-prothrombin-complex-concentrate-pcc-anticoagulation-faulknerh-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/safety-efficacy-prothrombin-complex-concentrate-pcc-anticoagulation-faulknerh-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/impact-disease-specific-treatment-non-selective-beta-blockers-risk-gonzalezhc-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/impact-disease-specific-treatment-non-selective-beta-blockers-risk-gonzalezhc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/impact-disease-specific-treatment-non-selective-beta-blockers-risk-gonzalezhc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/impact-disease-specific-treatment-non-selective-beta-blockers-risk-gonzalezhc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/point-of-care-mastoid-fontanelle-ultrasonography-diagnosis-bedside-follow-up-kocabx131yx131knnd-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/point-of-care-mastoid-fontanelle-ultrasonography-diagnosis-bedside-follow-up-kocabx131yx131knnd-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/point-of-care-mastoid-fontanelle-ultrasonography-diagnosis-bedside-follow-up-kocabx131yx131knnd-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/point-of-care-mastoid-fontanelle-ultrasonography-diagnosis-bedside-follow-up-kocabx131yx131knnd-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/nonheparin-bonded-stent-relining-case-subacute-in-stent-thrombosis-litvaka-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/nonheparin-bonded-stent-relining-case-subacute-in-stent-thrombosis-litvaka-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/nonheparin-bonded-stent-relining-case-subacute-in-stent-thrombosis-litvaka-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/nonheparin-bonded-stent-relining-case-subacute-in-stent-thrombosis-litvaka-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/meningococcal-meningitis-complicated-cerebral-venous-sinus-thrombosis-altellya-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/meningococcal-meningitis-complicated-cerebral-venous-sinus-thrombosis-altellya-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/meningococcal-meningitis-complicated-cerebral-venous-sinus-thrombosis-altellya-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/meningococcal-meningitis-complicated-cerebral-venous-sinus-thrombosis-altellya-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/influencing-factors-citrate-accumulation-critically-ill-patients-chenz-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/influencing-factors-citrate-accumulation-critically-ill-patients-chenz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/influencing-factors-citrate-accumulation-critically-ill-patients-chenz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/influencing-factors-citrate-accumulation-critically-ill-patients-chenz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/current-application-status-blood-purification-therapy-critically-zhengy-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/current-application-status-blood-purification-therapy-critically-zhengy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/current-application-status-blood-purification-therapy-critically-zhengy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/current-application-status-blood-purification-therapy-critically-zhengy-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/update-management-otogenic-cerebral-sinus-thrombosis-systematic-pictonc-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/update-management-otogenic-cerebral-sinus-thrombosis-systematic-pictonc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/update-management-otogenic-cerebral-sinus-thrombosis-systematic-pictonc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/update-management-otogenic-cerebral-sinus-thrombosis-systematic-pictonc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-outcomes-traumatic-cerebral-venous-sinus-injury-brownj-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-outcomes-traumatic-cerebral-venous-sinus-injury-brownj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-outcomes-traumatic-cerebral-venous-sinus-injury-brownj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-outcomes-traumatic-cerebral-venous-sinus-injury-brownj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/safety-efficacy-direct-oral-anticoagulants-children-infection-related-fiordelisia-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/safety-efficacy-direct-oral-anticoagulants-children-infection-related-fiordelisia-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/safety-efficacy-direct-oral-anticoagulants-children-infection-related-fiordelisia-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/safety-efficacy-direct-oral-anticoagulants-children-infection-related-fiordelisia-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/identifying-risk-factors-major-bleeding-patients-atrial-wangx-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/identifying-risk-factors-major-bleeding-patients-atrial-wangx-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/identifying-risk-factors-major-bleeding-patients-atrial-wangx-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/identifying-risk-factors-major-bleeding-patients-atrial-wangx-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/letter-management-pregnancies-history-venous-thromboembolism-low-dose-xuj-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/letter-management-pregnancies-history-venous-thromboembolism-low-dose-xuj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/letter-management-pregnancies-history-venous-thromboembolism-low-dose-xuj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/letter-management-pregnancies-history-venous-thromboembolism-low-dose-xuj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/multiple-site-venous-thromboembolism-acute-toxoplasmosis-report-two-reffoi-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/multiple-site-venous-thromboembolism-acute-toxoplasmosis-report-two-reffoi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/multiple-site-venous-thromboembolism-acute-toxoplasmosis-report-two-reffoi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/multiple-site-venous-thromboembolism-acute-toxoplasmosis-report-two-reffoi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/thrombosis-anticoagulation-patients-cirrhosis-overview-valladc-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/thrombosis-anticoagulation-patients-cirrhosis-overview-valladc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/thrombosis-anticoagulation-patients-cirrhosis-overview-valladc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/thrombosis-anticoagulation-patients-cirrhosis-overview-valladc-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pilot-multigenic-thrombophilic-risk-recurrent-pregnancy-loss-badulescuov-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pilot-multigenic-thrombophilic-risk-recurrent-pregnancy-loss-badulescuov-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pilot-multigenic-thrombophilic-risk-recurrent-pregnancy-loss-badulescuov-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pilot-multigenic-thrombophilic-risk-recurrent-pregnancy-loss-badulescuov-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/myeloproliferative-neoplasm-cause-splanchnic-vein-thrombosis-abboudb-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/myeloproliferative-neoplasm-cause-splanchnic-vein-thrombosis-abboudb-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/myeloproliferative-neoplasm-cause-splanchnic-vein-thrombosis-abboudb-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/myeloproliferative-neoplasm-cause-splanchnic-vein-thrombosis-abboudb-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/adrenal-hemorrhage-requiring-apixaban-reversal-setting-active-lichardim-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/adrenal-hemorrhage-requiring-apixaban-reversal-setting-active-lichardim-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/adrenal-hemorrhage-requiring-apixaban-reversal-setting-active-lichardim-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/adrenal-hemorrhage-requiring-apixaban-reversal-setting-active-lichardim-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/short-long-term-central-peripherally-inserted-catheters-gxf3mezcalceteroc-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/short-long-term-central-peripherally-inserted-catheters-gxf3mezcalceteroc-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/short-long-term-central-peripherally-inserted-catheters-gxf3mezcalceteroc-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/short-long-term-central-peripherally-inserted-catheters-gxf3mezcalceteroc-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/primary-prophylaxis-treatment-venous-thromboembolism-malignancy-focus-pintofg-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/primary-prophylaxis-treatment-venous-thromboembolism-malignancy-focus-pintofg-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/primary-prophylaxis-treatment-venous-thromboembolism-malignancy-focus-pintofg-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/primary-prophylaxis-treatment-venous-thromboembolism-malignancy-focus-pintofg-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparison-between-regional-citrate-anticoagulation-systemic-heparin-hirwea-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparison-between-regional-citrate-anticoagulation-systemic-heparin-hirwea-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparison-between-regional-citrate-anticoagulation-systemic-heparin-hirwea-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparison-between-regional-citrate-anticoagulation-systemic-heparin-hirwea-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-functionalized-scaffold-loaded-pleiotrophin-enhances-endothelialization-angiogenic-yadavcj-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-functionalized-scaffold-loaded-pleiotrophin-enhances-endothelialization-angiogenic-yadavcj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-functionalized-scaffold-loaded-pleiotrophin-enhances-endothelialization-angiogenic-yadavcj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-functionalized-scaffold-loaded-pleiotrophin-enhances-endothelialization-angiogenic-yadavcj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/complications-catheter-directed-interventions-acute-pulmonary-embolism-narrative-garcxedamartxedg-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/complications-catheter-directed-interventions-acute-pulmonary-embolism-narrative-garcxedamartxedg-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/complications-catheter-directed-interventions-acute-pulmonary-embolism-narrative-garcxedamartxedg-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/complications-catheter-directed-interventions-acute-pulmonary-embolism-narrative-garcxedamartxedg-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comment-sequential-anticoagulation-lmwh-doacs-cirrhotic-portal-mokkapatia-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comment-sequential-anticoagulation-lmwh-doacs-cirrhotic-portal-mokkapatia-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comment-sequential-anticoagulation-lmwh-doacs-cirrhotic-portal-mokkapatia-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comment-sequential-anticoagulation-lmwh-doacs-cirrhotic-portal-mokkapatia-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/atypical-pediatric-headache-outpatient-presentation-petrous-apicitis-harrismj-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/atypical-pediatric-headache-outpatient-presentation-petrous-apicitis-harrismj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/atypical-pediatric-headache-outpatient-presentation-petrous-apicitis-harrismj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/atypical-pediatric-headache-outpatient-presentation-petrous-apicitis-harrismj-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/preventing-vision-loss-pediatric-otogenic-thrombosis-case-almuhannafa-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/preventing-vision-loss-pediatric-otogenic-thrombosis-case-almuhannafa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/preventing-vision-loss-pediatric-otogenic-thrombosis-case-almuhannafa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/preventing-vision-loss-pediatric-otogenic-thrombosis-case-almuhannafa-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/andexanet-alfa-life-threatening-bleeding-following-factor-xa-sakamotok-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/andexanet-alfa-life-threatening-bleeding-following-factor-xa-sakamotok-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/andexanet-alfa-life-threatening-bleeding-following-factor-xa-sakamotok-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/andexanet-alfa-life-threatening-bleeding-following-factor-xa-sakamotok-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/regional-citrate-anticoagulation-crrt-successes-pitfalls-sustainability-desimonee-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/regional-citrate-anticoagulation-crrt-successes-pitfalls-sustainability-desimonee-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/regional-citrate-anticoagulation-crrt-successes-pitfalls-sustainability-desimonee-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/regional-citrate-anticoagulation-crrt-successes-pitfalls-sustainability-desimonee-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/artificial-intelligence-based-thrombotic-infectious-risk-factors-peripherally-rouvixe8reb-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/artificial-intelligence-based-thrombotic-infectious-risk-factors-peripherally-rouvixe8reb-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/artificial-intelligence-based-thrombotic-infectious-risk-factors-peripherally-rouvixe8reb-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/artificial-intelligence-based-thrombotic-infectious-risk-factors-peripherally-rouvixe8reb-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/real-world-rivaroxaban-primary-thromboprophylaxis-cardiac-thrombosis-treatment-derridjn-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/real-world-rivaroxaban-primary-thromboprophylaxis-cardiac-thrombosis-treatment-derridjn-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/real-world-rivaroxaban-primary-thromboprophylaxis-cardiac-thrombosis-treatment-derridjn-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/real-world-rivaroxaban-primary-thromboprophylaxis-cardiac-thrombosis-treatment-derridjn-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/thromboembolic-disease-testicular-germ-cell-tumors-real-world-evidence-albuquerquej-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/thromboembolic-disease-testicular-germ-cell-tumors-real-world-evidence-albuquerquej-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/thromboembolic-disease-testicular-germ-cell-tumors-real-world-evidence-albuquerquej-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/thromboembolic-disease-testicular-germ-cell-tumors-real-world-evidence-albuquerquej-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/clinical-management-portal-vein-thrombosis-cirrhosis-evidence-daik-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/clinical-management-portal-vein-thrombosis-cirrhosis-evidence-daik-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/clinical-management-portal-vein-thrombosis-cirrhosis-evidence-daik-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/clinical-management-portal-vein-thrombosis-cirrhosis-evidence-daik-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/extending-venous-thromboembolism-secondary-prevention-apixaban-cancer-mcbanerd-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/extending-venous-thromboembolism-secondary-prevention-apixaban-cancer-mcbanerd-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/extending-venous-thromboembolism-secondary-prevention-apixaban-cancer-mcbanerd-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/extending-venous-thromboembolism-secondary-prevention-apixaban-cancer-mcbanerd-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/incidence-venous-thromboembolism-curative-colon-cancer-surgery-baastrupnn-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/incidence-venous-thromboembolism-curative-colon-cancer-surgery-baastrupnn-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/incidence-venous-thromboembolism-curative-colon-cancer-surgery-baastrupnn-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/incidence-venous-thromboembolism-curative-colon-cancer-surgery-baastrupnn-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/aspirin-not-everyone-discharge-non-home-facilities-total-mchughm-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/aspirin-not-everyone-discharge-non-home-facilities-total-mchughm-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/aspirin-not-everyone-discharge-non-home-facilities-total-mchughm-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/aspirin-not-everyone-discharge-non-home-facilities-total-mchughm-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/aspirin-enoxaparin-vte-prophylaxis-primary-partial-total-x-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/aspirin-enoxaparin-vte-prophylaxis-primary-partial-total-x-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/aspirin-enoxaparin-vte-prophylaxis-primary-partial-total-x-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/aspirin-enoxaparin-vte-prophylaxis-primary-partial-total-x-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/outcomes-following-interval-delayed-first-rib-resection-minchup-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/outcomes-following-interval-delayed-first-rib-resection-minchup-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/outcomes-following-interval-delayed-first-rib-resection-minchup-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/outcomes-following-interval-delayed-first-rib-resection-minchup-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/interventional-therapy-upper-extremity-phlegmasia-cerulea-dolens-hidalgooviedojm-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/interventional-therapy-upper-extremity-phlegmasia-cerulea-dolens-hidalgooviedojm-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/interventional-therapy-upper-extremity-phlegmasia-cerulea-dolens-hidalgooviedojm-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/interventional-therapy-upper-extremity-phlegmasia-cerulea-dolens-hidalgooviedojm-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/translation-french-republication-management-cancer-associated-thromboembolism-vulnerable-laportes-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/translation-french-republication-management-cancer-associated-thromboembolism-vulnerable-laportes-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/translation-french-republication-management-cancer-associated-thromboembolism-vulnerable-laportes-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/translation-french-republication-management-cancer-associated-thromboembolism-vulnerable-laportes-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/paget-schroetter-syndrome-patient-posterior-shoulder-subluxation-case-rxf6thlisbergerd-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/paget-schroetter-syndrome-patient-posterior-shoulder-subluxation-case-rxf6thlisbergerd-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/paget-schroetter-syndrome-patient-posterior-shoulder-subluxation-case-rxf6thlisbergerd-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/paget-schroetter-syndrome-patient-posterior-shoulder-subluxation-case-rxf6thlisbergerd-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cost-effectiveness-enoxaparin-aspirin-prevention-venous-thromboembolism-total-x-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cost-effectiveness-enoxaparin-aspirin-prevention-venous-thromboembolism-total-x-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cost-effectiveness-enoxaparin-aspirin-prevention-venous-thromboembolism-total-x-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cost-effectiveness-enoxaparin-aspirin-prevention-venous-thromboembolism-total-x-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/chemokine-oligomers-impact-fondaparinux-binding-szekeresgp-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/chemokine-oligomers-impact-fondaparinux-binding-szekeresgp-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/chemokine-oligomers-impact-fondaparinux-binding-szekeresgp-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/chemokine-oligomers-impact-fondaparinux-binding-szekeresgp-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/multifaceted-cerebral-venous-thrombosis-extensive-intra-cerebral-hemorrhage-alqahtanibg-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/multifaceted-cerebral-venous-thrombosis-extensive-intra-cerebral-hemorrhage-alqahtanibg-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/multifaceted-cerebral-venous-thrombosis-extensive-intra-cerebral-hemorrhage-alqahtanibg-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/multifaceted-cerebral-venous-thrombosis-extensive-intra-cerebral-hemorrhage-alqahtanibg-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/clinical-economic-implications-false-positive-heparin-induced-thrombocytopenia-immunoassays-dweckb-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/clinical-economic-implications-false-positive-heparin-induced-thrombocytopenia-immunoassays-dweckb-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/clinical-economic-implications-false-positive-heparin-induced-thrombocytopenia-immunoassays-dweckb-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/clinical-economic-implications-false-positive-heparin-induced-thrombocytopenia-immunoassays-dweckb-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pharmacotherapy-venous-thromboprophylaxis-following-total-hip-knee-yongbsj-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pharmacotherapy-venous-thromboprophylaxis-following-total-hip-knee-yongbsj-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pharmacotherapy-venous-thromboprophylaxis-following-total-hip-knee-yongbsj-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pharmacotherapy-venous-thromboprophylaxis-following-total-hip-knee-yongbsj-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/risks-major-bleeding-venous-thromboembolism-patients-undergoing-smeetsmjr-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/risks-major-bleeding-venous-thromboembolism-patients-undergoing-smeetsmjr-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/risks-major-bleeding-venous-thromboembolism-patients-undergoing-smeetsmjr-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/risks-major-bleeding-venous-thromboembolism-patients-undergoing-smeetsmjr-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/paget-schroetter-syndrome-case-young-weightlifter-crosslanddt-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/paget-schroetter-syndrome-case-young-weightlifter-crosslanddt-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/paget-schroetter-syndrome-case-young-weightlifter-crosslanddt-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/paget-schroetter-syndrome-case-young-weightlifter-crosslanddt-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/treatment-superficial-thrombophlebitis-leg-dinisiom-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/treatment-superficial-thrombophlebitis-leg-dinisiom-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/treatment-superficial-thrombophlebitis-leg-dinisiom-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/treatment-superficial-thrombophlebitis-leg-dinisiom-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-management-first-five-days-infant-pediatric-extracorporeal-binghamkr-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-management-first-five-days-infant-pediatric-extracorporeal-binghamkr-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-management-first-five-days-infant-pediatric-extracorporeal-binghamkr-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-management-first-five-days-infant-pediatric-extracorporeal-binghamkr-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/off-label-4-factor-prothrombin-complex-concentrate-common-despite-scharmancd-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/off-label-4-factor-prothrombin-complex-concentrate-common-despite-scharmancd-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/off-label-4-factor-prothrombin-complex-concentrate-common-despite-scharmancd-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/off-label-4-factor-prothrombin-complex-concentrate-common-despite-scharmancd-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/thrombophilia-recurrent-pregnancy-loss-enigma-continues-barutmu-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/thrombophilia-recurrent-pregnancy-loss-enigma-continues-barutmu-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/thrombophilia-recurrent-pregnancy-loss-enigma-continues-barutmu-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/thrombophilia-recurrent-pregnancy-loss-enigma-continues-barutmu-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulants-current-topics-morishitae-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulants-current-topics-morishitae-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulants-current-topics-morishitae-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulants-current-topics-morishitae-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-advances-diagnosis-treatment-tritschlert-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-advances-diagnosis-treatment-tritschlert-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-advances-diagnosis-treatment-tritschlert-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-advances-diagnosis-treatment-tritschlert-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/extended-treatment-venous-thromboembolism-systematic-review-network-wangkl-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/extended-treatment-venous-thromboembolism-systematic-review-network-wangkl-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/extended-treatment-venous-thromboembolism-systematic-review-network-wangkl-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/extended-treatment-venous-thromboembolism-systematic-review-network-wangkl-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/treatment-lower-extremity-superficial-thrombophlebitis-dinisiom-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/treatment-lower-extremity-superficial-thrombophlebitis-dinisiom-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/treatment-lower-extremity-superficial-thrombophlebitis-dinisiom-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/treatment-lower-extremity-superficial-thrombophlebitis-dinisiom-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/treatment-superficial-vein-thrombosis-systematic-review-meta-analysis-duffettl-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/treatment-superficial-vein-thrombosis-systematic-review-meta-analysis-duffettl-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/treatment-superficial-vein-thrombosis-systematic-review-meta-analysis-duffettl-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/treatment-superficial-vein-thrombosis-systematic-review-meta-analysis-duffettl-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/extended-anticoagulation-secondary-prevention-venous-thromboembolic-events-maiv-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/extended-anticoagulation-secondary-prevention-venous-thromboembolic-events-maiv-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/extended-anticoagulation-secondary-prevention-venous-thromboembolic-events-maiv-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/extended-anticoagulation-secondary-prevention-venous-thromboembolic-events-maiv-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prothrombin-complex-concentrate-vitamin-k-antagonist-reversal-ostermannh-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prothrombin-complex-concentrate-vitamin-k-antagonist-reversal-ostermannh-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prothrombin-complex-concentrate-vitamin-k-antagonist-reversal-ostermannh-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prothrombin-complex-concentrate-vitamin-k-antagonist-reversal-ostermannh-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/which-patients-unprovoked-venous-thromboembolism-should-receive-djulbegovicm-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/which-patients-unprovoked-venous-thromboembolism-should-receive-djulbegovicm-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/which-patients-unprovoked-venous-thromboembolism-should-receive-djulbegovicm-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/which-patients-unprovoked-venous-thromboembolism-should-receive-djulbegovicm-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prothrombin-complex-concentrate-warfarin-reversal-patients-continuous-flow-jenningsdl-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prothrombin-complex-concentrate-warfarin-reversal-patients-continuous-flow-jenningsdl-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prothrombin-complex-concentrate-warfarin-reversal-patients-continuous-flow-jenningsdl-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prothrombin-complex-concentrate-warfarin-reversal-patients-continuous-flow-jenningsdl-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/extended-treatment-edoxaban-cancer-patients-venous-thromboembolism-dinisiom-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/extended-treatment-edoxaban-cancer-patients-venous-thromboembolism-dinisiom-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/extended-treatment-edoxaban-cancer-patients-venous-thromboembolism-dinisiom-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/extended-treatment-edoxaban-cancer-patients-venous-thromboembolism-dinisiom-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/thromboembolic-risk-4-factor-prothrombin-complex-concentrate-fresh-maguirem-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/thromboembolic-risk-4-factor-prothrombin-complex-concentrate-fresh-maguirem-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/thromboembolic-risk-4-factor-prothrombin-complex-concentrate-fresh-maguirem-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/thromboembolic-risk-4-factor-prothrombin-complex-concentrate-fresh-maguirem-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-warkentin-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-warkentin-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-warkentin-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-warkentin-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/aeromonas-species-mackay-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/aeromonas-species-mackay-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/aeromonas-species-mackay-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/aeromonas-species-mackay-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cost-effectiveness-wade-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cost-effectiveness-wade-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cost-effectiveness-wade-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cost-effectiveness-wade-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/stimulating-destabilase-chalisova-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/stimulating-destabilase-chalisova-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/stimulating-destabilase-chalisova-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/stimulating-destabilase-chalisova-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulant-therapy-choy-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulant-therapy-choy-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulant-therapy-choy-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulant-therapy-choy-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/treatment-thurner-seidensticker-1998 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/treatment-thurner-seidensticker-1998 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/treatment-thurner-seidensticker-1998 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/treatment-thurner-seidensticker-1998 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/gliarin-macrolin-xu-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/gliarin-macrolin-xu-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/gliarin-macrolin-xu-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/gliarin-macrolin-xu-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/current-treatment-ranze-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/current-treatment-ranze-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/current-treatment-ranze-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/current-treatment-ranze-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-merli-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-merli-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-merli-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-merli-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/relative-roles-shaw-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/relative-roles-shaw-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/relative-roles-shaw-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/relative-roles-shaw-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/building-effective-agnelli-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/building-effective-agnelli-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/building-effective-agnelli-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/building-effective-agnelli-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-lassen-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-lassen-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-lassen-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-lassen-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/recombinant-hirudin-fischer-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/recombinant-hirudin-fischer-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/recombinant-hirudin-fischer-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/recombinant-hirudin-fischer-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/postingestive-chemosensation-kornreich-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/postingestive-chemosensation-kornreich-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/postingestive-chemosensation-kornreich-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/postingestive-chemosensation-kornreich-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/treatment-heparin-greinacher-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/treatment-heparin-greinacher-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/treatment-heparin-greinacher-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/treatment-heparin-greinacher-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-anticoagulant-koster-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-anticoagulant-koster-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-anticoagulant-koster-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-anticoagulant-koster-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cellulitis-caused-de-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cellulitis-caused-de-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cellulitis-caused-de-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cellulitis-caused-de-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-greinacher-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-greinacher-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-greinacher-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-greinacher-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/successful-medicinal-shenfeld-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/successful-medicinal-shenfeld-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/successful-medicinal-shenfeld-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/successful-medicinal-shenfeld-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-miric-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-miric-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-miric-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-miric-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/disruption-peripheral-johnson-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/disruption-peripheral-johnson-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/disruption-peripheral-johnson-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/disruption-peripheral-johnson-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/current-status-oger-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/current-status-oger-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/current-status-oger-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/current-status-oger-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/segmental-control-wilson-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/segmental-control-wilson-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/segmental-control-wilson-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/segmental-control-wilson-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-lee-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-lee-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-lee-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-lee-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/continuous-haemofiltration-schneider-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/continuous-haemofiltration-schneider-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/continuous-haemofiltration-schneider-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/continuous-haemofiltration-schneider-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prophylaxis-treatment-breddin-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prophylaxis-treatment-breddin-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prophylaxis-treatment-breddin-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prophylaxis-treatment-breddin-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-ruban-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-ruban-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-ruban-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-ruban-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/functionally-heterogeneous-hocker-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/functionally-heterogeneous-hocker-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/functionally-heterogeneous-hocker-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/functionally-heterogeneous-hocker-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-patients-lubenow-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-patients-lubenow-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-patients-lubenow-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-patients-lubenow-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-percutaneous-topol-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-percutaneous-topol-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-percutaneous-topol-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-percutaneous-topol-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-patients-campbell-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-patients-campbell-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-patients-campbell-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-patients-campbell-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/dosage-pharmacological-lui-2000 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/dosage-pharmacological-lui-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/dosage-pharmacological-lui-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/dosage-pharmacological-lui-2000 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-gustafsson-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-gustafsson-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-gustafsson-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-gustafsson-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-baglin-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-baglin-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-baglin-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-baglin-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/molecular-weight-cirlincione-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/molecular-weight-cirlincione-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/molecular-weight-cirlincione-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/molecular-weight-cirlincione-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-lankes-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-lankes-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-lankes-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-lankes-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/medicinal-leeches-gur-1999 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/medicinal-leeches-gur-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/medicinal-leeches-gur-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/medicinal-leeches-gur-1999 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/fingertip-replantation-akyurek-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/fingertip-replantation-akyurek-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/fingertip-replantation-akyurek-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/fingertip-replantation-akyurek-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/mechanical-prophylaxis-stannard-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/mechanical-prophylaxis-stannard-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/mechanical-prophylaxis-stannard-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/mechanical-prophylaxis-stannard-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/functional-analyses-friesen-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/functional-analyses-friesen-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/functional-analyses-friesen-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/functional-analyses-friesen-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-percutaneous-bates-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-percutaneous-bates-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-percutaneous-bates-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-percutaneous-bates-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prolonged-vivo-sheffield-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prolonged-vivo-sheffield-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prolonged-vivo-sheffield-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prolonged-vivo-sheffield-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bitter-substances-li-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bitter-substances-li-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bitter-substances-li-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bitter-substances-li-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-anticoagulant-cameron-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-anticoagulant-cameron-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-anticoagulant-cameron-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-anticoagulant-cameron-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-universal-menssen-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-universal-menssen-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-universal-menssen-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-universal-menssen-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/roles-endogenous-calabrese-1979 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/roles-endogenous-calabrese-1979 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/roles-endogenous-calabrese-1979 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/roles-endogenous-calabrese-1979 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/model-intersegmental-hill-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/model-intersegmental-hill-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/model-intersegmental-hill-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/model-intersegmental-hill-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prevention-deep-michot-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prevention-deep-michot-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prevention-deep-michot-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prevention-deep-michot-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/monitoring-direct-de-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/monitoring-direct-de-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/monitoring-direct-de-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/monitoring-direct-de-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/argatroban-kathiresan-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/argatroban-kathiresan-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/argatroban-kathiresan-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/argatroban-kathiresan-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/nosocomial-infections-sartor-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/nosocomial-infections-sartor-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/nosocomial-infections-sartor-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/nosocomial-infections-sartor-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-kaplan-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-kaplan-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-kaplan-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-kaplan-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/current-controversies-dahl-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/current-controversies-dahl-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/current-controversies-dahl-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/current-controversies-dahl-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/continuous-free-kamolz-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/continuous-free-kamolz-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/continuous-free-kamolz-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/continuous-free-kamolz-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-weitz-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-weitz-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-weitz-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-weitz-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/upper-extremity-joffe-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/upper-extremity-joffe-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/upper-extremity-joffe-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/upper-extremity-joffe-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/proximal-deep-lieberman-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/proximal-deep-lieberman-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/proximal-deep-lieberman-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/proximal-deep-lieberman-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-eriksson-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-eriksson-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-eriksson-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-eriksson-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/vivo-dynamics-baker-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/vivo-dynamics-baker-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/vivo-dynamics-baker-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/vivo-dynamics-baker-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/dependent-release-walz-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/dependent-release-walz-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/dependent-release-walz-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/dependent-release-walz-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pharmacotherapy-heparin-dager-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pharmacotherapy-heparin-dager-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pharmacotherapy-heparin-dager-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pharmacotherapy-heparin-dager-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-thrombophilia-bauer-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-thrombophilia-bauer-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-thrombophilia-bauer-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-thrombophilia-bauer-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-warkentin-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-warkentin-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-warkentin-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-warkentin-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/oral-direct-gustafsson-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/oral-direct-gustafsson-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/oral-direct-gustafsson-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/oral-direct-gustafsson-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-maffrand-1992 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-maffrand-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-maffrand-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-maffrand-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/studies-mechanism-markwardt-1956 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/studies-mechanism-markwardt-1956 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/studies-mechanism-markwardt-1956 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/studies-mechanism-markwardt-1956 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/target-influences-french-1992 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/target-influences-french-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/target-influences-french-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/target-influences-french-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/orgaran-heparin-chong-1992 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/orgaran-heparin-chong-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/orgaran-heparin-chong-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/orgaran-heparin-chong-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-percutaneous-caron-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-percutaneous-caron-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-percutaneous-caron-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-percutaneous-caron-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-warkentin-2003-2 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-warkentin-2003-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-warkentin-2003-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-warkentin-2003-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cloning-expression-dykes-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cloning-expression-dykes-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cloning-expression-dykes-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cloning-expression-dykes-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/argatroban-treatment-cleveland-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/argatroban-treatment-cleveland-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/argatroban-treatment-cleveland-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/argatroban-treatment-cleveland-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulant-efficacy-poschel-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulant-efficacy-poschel-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulant-efficacy-poschel-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulant-efficacy-poschel-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-ambrosetti-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-ambrosetti-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-ambrosetti-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-ambrosetti-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/drugs-prevention-lubenow-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/drugs-prevention-lubenow-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/drugs-prevention-lubenow-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/drugs-prevention-lubenow-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-nutescu-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-nutescu-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-nutescu-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-nutescu-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/analysis-modeling-wittenberg-1992 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/analysis-modeling-wittenberg-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/analysis-modeling-wittenberg-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/analysis-modeling-wittenberg-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prevention-deep-eichinger-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prevention-deep-eichinger-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prevention-deep-eichinger-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prevention-deep-eichinger-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/nursing-initiatives-morris-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/nursing-initiatives-morris-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/nursing-initiatives-morris-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/nursing-initiatives-morris-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-anticoagulant-bates-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-anticoagulant-bates-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-anticoagulant-bates-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-anticoagulant-bates-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/lepirudin-bivalent-greinacher-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/lepirudin-bivalent-greinacher-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/lepirudin-bivalent-greinacher-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/lepirudin-bivalent-greinacher-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-fritsma-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-fritsma-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-fritsma-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-fritsma-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/ximelagatran-oral-mccullough-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/ximelagatran-oral-mccullough-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/ximelagatran-oral-mccullough-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/ximelagatran-oral-mccullough-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/aeromonas-hydrophila-lineaweaver-1992 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/aeromonas-hydrophila-lineaweaver-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/aeromonas-hydrophila-lineaweaver-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/aeromonas-hydrophila-lineaweaver-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/postprandial-aeromonas-lineaweaver-1992 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/postprandial-aeromonas-lineaweaver-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/postprandial-aeromonas-lineaweaver-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/postprandial-aeromonas-lineaweaver-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/leech-filamin-venkitaramani-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/leech-filamin-venkitaramani-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/leech-filamin-venkitaramani-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/leech-filamin-venkitaramani-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-brighton-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-brighton-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-brighton-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-brighton-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-mckenzie-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-mckenzie-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-mckenzie-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-mckenzie-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/digital-replantation-brasier-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/digital-replantation-brasier-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/digital-replantation-brasier-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/digital-replantation-brasier-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-gurbuz-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-gurbuz-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-gurbuz-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-gurbuz-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/suppurative-sequelae-steer-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/suppurative-sequelae-steer-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/suppurative-sequelae-steer-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/suppurative-sequelae-steer-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/thrombin-ideal-gurm-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/thrombin-ideal-gurm-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/thrombin-ideal-gurm-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/thrombin-ideal-gurm-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prophylaxis-treatment-gutt-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prophylaxis-treatment-gutt-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prophylaxis-treatment-gutt-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prophylaxis-treatment-gutt-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-kokolis-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-kokolis-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-kokolis-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-kokolis-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/mechanisms-postinhibitory-angstadt-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/mechanisms-postinhibitory-angstadt-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/mechanisms-postinhibitory-angstadt-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/mechanisms-postinhibitory-angstadt-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/distal-very-foucher-1992 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/distal-very-foucher-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/distal-very-foucher-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/distal-very-foucher-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/ximelagatran-orally-gulseth-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/ximelagatran-orally-gulseth-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/ximelagatran-orally-gulseth-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/ximelagatran-orally-gulseth-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-based-lindemann-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-based-lindemann-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-based-lindemann-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-based-lindemann-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/oral-direct-mohapatra-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/oral-direct-mohapatra-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/oral-direct-mohapatra-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/oral-direct-mohapatra-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulants-weitz-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulants-weitz-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulants-weitz-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulants-weitz-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-patients-moen-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-patients-moen-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-patients-moen-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-patients-moen-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/mechanism-action-mattsson-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/mechanism-action-mattsson-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/mechanism-action-mattsson-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/mechanism-action-mattsson-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-di-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-di-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-di-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-di-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pharmacology-potential-linkins-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pharmacology-potential-linkins-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pharmacology-potential-linkins-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pharmacology-potential-linkins-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/thrombosis-coagulation-anaya-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/thrombosis-coagulation-anaya-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/thrombosis-coagulation-anaya-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/thrombosis-coagulation-anaya-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/monitoring-free-top-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/monitoring-free-top-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/monitoring-free-top-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/monitoring-free-top-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-versus-kopp-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-versus-kopp-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-versus-kopp-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-versus-kopp-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-current-west-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-current-west-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-current-west-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-current-west-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-fletcher-1992 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-fletcher-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-fletcher-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-fletcher-1992 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/molecular-characterization-dykes-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/molecular-characterization-dykes-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/molecular-characterization-dykes-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/molecular-characterization-dykes-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prophylaxis-against-stannard-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prophylaxis-against-stannard-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prophylaxis-against-stannard-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prophylaxis-against-stannard-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/development-bivalirudin-serruys-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/development-bivalirudin-serruys-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/development-bivalirudin-serruys-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/development-bivalirudin-serruys-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/ximelagatran-choudhury-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/ximelagatran-choudhury-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/ximelagatran-choudhury-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/ximelagatran-choudhury-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/risk-factors-smith-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/risk-factors-smith-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/risk-factors-smith-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/risk-factors-smith-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/modification-leech-brodfuehrer-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/modification-leech-brodfuehrer-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/modification-leech-brodfuehrer-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/modification-leech-brodfuehrer-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-kehlpruett-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-kehlpruett-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-kehlpruett-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-kehlpruett-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/central-pattern-norris-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/central-pattern-norris-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/central-pattern-norris-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/central-pattern-norris-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/spike-mediated-ivanov-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/spike-mediated-ivanov-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/spike-mediated-ivanov-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/spike-mediated-ivanov-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/graded-inhibitory-ivanov-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/graded-inhibitory-ivanov-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/graded-inhibitory-ivanov-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/graded-inhibitory-ivanov-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/proximal-deep-nathan-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/proximal-deep-nathan-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/proximal-deep-nathan-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/proximal-deep-nathan-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/argatroban-direct-escolar-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/argatroban-direct-escolar-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/argatroban-direct-escolar-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/argatroban-direct-escolar-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/practice-patterns-beekman-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/practice-patterns-beekman-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/practice-patterns-beekman-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/practice-patterns-beekman-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-daneschvar-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-daneschvar-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-daneschvar-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-daneschvar-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/neuromodulatory-acetylcholine-gascoigne-1991 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/neuromodulatory-acetylcholine-gascoigne-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/neuromodulatory-acetylcholine-gascoigne-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/neuromodulatory-acetylcholine-gascoigne-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/serotonin-released-glover-1991 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/serotonin-released-glover-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/serotonin-released-glover-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/serotonin-released-glover-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/acetyl-carnitine-ristori-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/acetyl-carnitine-ristori-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/acetyl-carnitine-ristori-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/acetyl-carnitine-ristori-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-baroletti-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-baroletti-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-baroletti-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-baroletti-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/mechanism-action-kyriakides-1990 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/mechanism-action-kyriakides-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/mechanism-action-kyriakides-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/mechanism-action-kyriakides-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/imaging-dedicated-briggman-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/imaging-dedicated-briggman-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/imaging-dedicated-briggman-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/imaging-dedicated-briggman-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-schwienhorst-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-schwienhorst-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-schwienhorst-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-schwienhorst-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/systematic-deep-leonardi-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/systematic-deep-leonardi-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/systematic-deep-leonardi-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/systematic-deep-leonardi-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-cooney-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-cooney-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-cooney-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-cooney-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulants-bauer-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulants-bauer-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulants-bauer-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulants-bauer-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/glycoprotein-iiia-said-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/glycoprotein-iiia-said-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/glycoprotein-iiia-said-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/glycoprotein-iiia-said-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-acute-lee-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-acute-lee-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-acute-lee-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-acute-lee-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/inhibition-atpase-scuri-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/inhibition-atpase-scuri-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/inhibition-atpase-scuri-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/inhibition-atpase-scuri-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/adenovirus-mediated-cabric-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/adenovirus-mediated-cabric-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/adenovirus-mediated-cabric-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/adenovirus-mediated-cabric-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/ximelagatran-direct-ho-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/ximelagatran-direct-ho-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/ximelagatran-direct-ho-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/ximelagatran-direct-ho-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/infection-aeromonas-kalbermatten-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/infection-aeromonas-kalbermatten-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/infection-aeromonas-kalbermatten-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/infection-aeromonas-kalbermatten-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-testa-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-testa-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-testa-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-testa-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulants-stone-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulants-stone-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulants-stone-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulants-stone-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-acute-lepor-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-acute-lepor-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-acute-lepor-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-acute-lepor-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-mureebe-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-mureebe-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-mureebe-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-mureebe-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/fondaparinux-versus-warkentin-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/fondaparinux-versus-warkentin-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/fondaparinux-versus-warkentin-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/fondaparinux-versus-warkentin-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/monitoring-microvascular-schrey-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/monitoring-microvascular-schrey-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/monitoring-microvascular-schrey-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/monitoring-microvascular-schrey-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/safety-deep-chibbaro-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/safety-deep-chibbaro-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/safety-deep-chibbaro-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/safety-deep-chibbaro-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/varicose-vein-abbott-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/varicose-vein-abbott-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/varicose-vein-abbott-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/varicose-vein-abbott-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulants-bauersachs-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulants-bauersachs-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulants-bauersachs-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulants-bauersachs-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-kozeklangenecker-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-kozeklangenecker-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-kozeklangenecker-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-kozeklangenecker-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/current-future-harenberg-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/current-future-harenberg-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/current-future-harenberg-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/current-future-harenberg-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pharmacokinetics-pharmacodynamics-stangier-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pharmacokinetics-pharmacodynamics-stangier-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pharmacokinetics-pharmacodynamics-stangier-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pharmacokinetics-pharmacodynamics-stangier-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-venous-noble-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-venous-noble-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-venous-noble-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-venous-noble-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficacy-postoperative-turpie-1991 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficacy-postoperative-turpie-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficacy-postoperative-turpie-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficacy-postoperative-turpie-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/steroids-histamine-baskova-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/steroids-histamine-baskova-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/steroids-histamine-baskova-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/steroids-histamine-baskova-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulant-strategies-mccann-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulant-strategies-mccann-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulant-strategies-mccann-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulant-strategies-mccann-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/newly-diagnosed-goldhaber-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/newly-diagnosed-goldhaber-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/newly-diagnosed-goldhaber-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/newly-diagnosed-goldhaber-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/percutaneous-coronary-ramana-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/percutaneous-coronary-ramana-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/percutaneous-coronary-ramana-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/percutaneous-coronary-ramana-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-anticoagulant-markwardt-1991 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-anticoagulant-markwardt-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-anticoagulant-markwardt-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-anticoagulant-markwardt-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/laboratory-assays-walenga-1991 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/laboratory-assays-walenga-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/laboratory-assays-walenga-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/laboratory-assays-walenga-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-selleng-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-selleng-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-selleng-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-selleng-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-reingardiene-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-reingardiene-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-reingardiene-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-reingardiene-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/influence-infusions-ibbotson-1991 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/influence-infusions-ibbotson-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/influence-infusions-ibbotson-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/influence-infusions-ibbotson-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-gounden-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-gounden-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-gounden-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-gounden-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-direct-yeh-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-direct-yeh-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-direct-yeh-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-direct-yeh-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-zhu-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-zhu-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-zhu-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-zhu-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-james-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-james-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-james-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-james-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/antithrombotics-indigenous-mukherjee-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/antithrombotics-indigenous-mukherjee-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/antithrombotics-indigenous-mukherjee-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/antithrombotics-indigenous-mukherjee-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-promising-aiach-1991 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-promising-aiach-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-promising-aiach-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-promising-aiach-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prophylaxis-deep-goel-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prophylaxis-deep-goel-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prophylaxis-deep-goel-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prophylaxis-deep-goel-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-derivatives-markwardt-1991 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-derivatives-markwardt-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-derivatives-markwardt-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-derivatives-markwardt-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/oblique-muscle-jellies-1991 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/oblique-muscle-jellies-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/oblique-muscle-jellies-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/oblique-muscle-jellies-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/duration-deep-bergqvist-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/duration-deep-bergqvist-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/duration-deep-bergqvist-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/duration-deep-bergqvist-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-calfon-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-calfon-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-calfon-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-calfon-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-rupprecht-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-rupprecht-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-rupprecht-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-rupprecht-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/biochemical-pharmacological-deinum-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/biochemical-pharmacological-deinum-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/biochemical-pharmacological-deinum-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/biochemical-pharmacological-deinum-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/favorable-therapeutic-wong-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/favorable-therapeutic-wong-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/favorable-therapeutic-wong-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/favorable-therapeutic-wong-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-giraud-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-giraud-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-giraud-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-giraud-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-factor-turpie-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-factor-turpie-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-factor-turpie-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-factor-turpie-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-syed-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-syed-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-syed-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-syed-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-steffel-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-steffel-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-steffel-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-steffel-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pharmacology-pharmacokinetics-stangier-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pharmacology-pharmacokinetics-stangier-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pharmacology-pharmacokinetics-stangier-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pharmacology-pharmacokinetics-stangier-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/action-fmrfamide-norris-1990 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/action-fmrfamide-norris-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/action-fmrfamide-norris-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/action-fmrfamide-norris-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/modification-leech-ogara-1991 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/modification-leech-ogara-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/modification-leech-ogara-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/modification-leech-ogara-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/dabigatran-direct-bogatkevich-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/dabigatran-direct-bogatkevich-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/dabigatran-direct-bogatkevich-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/dabigatran-direct-bogatkevich-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-jenkins-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-jenkins-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-jenkins-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-jenkins-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-weber-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-weber-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-weber-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-weber-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pregnancy-associated-james-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pregnancy-associated-james-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pregnancy-associated-james-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pregnancy-associated-james-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/plasma-exchange-despotis-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/plasma-exchange-despotis-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/plasma-exchange-despotis-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/plasma-exchange-despotis-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-arepally-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-arepally-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-arepally-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-arepally-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-goldenberg-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-goldenberg-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-goldenberg-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-goldenberg-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/factors-influencing-kruse-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/factors-influencing-kruse-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/factors-influencing-kruse-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/factors-influencing-kruse-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-thrombin-raaz-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-thrombin-raaz-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-thrombin-raaz-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-thrombin-raaz-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/recombinant-factor-vavra-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/recombinant-factor-vavra-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/recombinant-factor-vavra-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/recombinant-factor-vavra-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/dabigatran-etexilate-van-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/dabigatran-etexilate-van-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/dabigatran-etexilate-van-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/dabigatran-etexilate-van-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/dabigatran-etexilate-siddiqui-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/dabigatran-etexilate-siddiqui-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/dabigatran-etexilate-siddiqui-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/dabigatran-etexilate-siddiqui-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/boehringer-launches-anon-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/boehringer-launches-anon-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/boehringer-launches-anon-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/boehringer-launches-anon-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/apixaban-direct-wong-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/apixaban-direct-wong-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/apixaban-direct-wong-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/apixaban-direct-wong-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/receptor-protein-sethi-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/receptor-protein-sethi-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/receptor-protein-sethi-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/receptor-protein-sethi-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulant-mechanism-lindhout-1990 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulant-mechanism-lindhout-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulant-mechanism-lindhout-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulant-mechanism-lindhout-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/physiology-water-friesen-1981 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/physiology-water-friesen-1981 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/physiology-water-friesen-1981 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/physiology-water-friesen-1981 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/sensory-system-brodfuehrer-1984 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/sensory-system-brodfuehrer-1984 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/sensory-system-brodfuehrer-1984 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/sensory-system-brodfuehrer-1984 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/parenteral-anticoagulants-gomezoutes-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/parenteral-anticoagulants-gomezoutes-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/parenteral-anticoagulants-gomezoutes-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/parenteral-anticoagulants-gomezoutes-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-dalainas-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-dalainas-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-dalainas-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-dalainas-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-management-streiff-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-management-streiff-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-management-streiff-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-management-streiff-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prolonged-bivalirudin-moser-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prolonged-bivalirudin-moser-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prolonged-bivalirudin-moser-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prolonged-bivalirudin-moser-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/s35972-direct-rupin-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/s35972-direct-rupin-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/s35972-direct-rupin-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/s35972-direct-rupin-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/oral-anticoagulant-dumont-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/oral-anticoagulant-dumont-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/oral-anticoagulant-dumont-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/oral-anticoagulant-dumont-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/coping-variability-calabrese-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/coping-variability-calabrese-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/coping-variability-calabrese-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/coping-variability-calabrese-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-anastomoses-zhang-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-anastomoses-zhang-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-anastomoses-zhang-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-anastomoses-zhang-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/dabigatran-etexilate-blommel-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/dabigatran-etexilate-blommel-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/dabigatran-etexilate-blommel-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/dabigatran-etexilate-blommel-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/diagnosis-management-emadi-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/diagnosis-management-emadi-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/diagnosis-management-emadi-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/diagnosis-management-emadi-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prophylaxis-deep-galanis-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prophylaxis-deep-galanis-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prophylaxis-deep-galanis-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prophylaxis-deep-galanis-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/advances-anticoagulation-augoustides-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/advances-anticoagulation-augoustides-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/advances-anticoagulation-augoustides-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/advances-anticoagulation-augoustides-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prophylaxis-deep-merli-1990 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prophylaxis-deep-merli-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prophylaxis-deep-merli-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prophylaxis-deep-merli-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/specialized-brain-mullins-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/specialized-brain-mullins-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/specialized-brain-mullins-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/specialized-brain-mullins-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-warkentin-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-warkentin-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-warkentin-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-warkentin-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-linkins-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-linkins-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-linkins-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-linkins-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-brunelli-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-brunelli-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-brunelli-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-brunelli-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/unusual-hospital-buiting-1990 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/unusual-hospital-buiting-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/unusual-hospital-buiting-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/unusual-hospital-buiting-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/safety-bivalirudin-sardi-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/safety-bivalirudin-sardi-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/safety-bivalirudin-sardi-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/safety-bivalirudin-sardi-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/segmental-specialization-wittenberg-1990 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/segmental-specialization-wittenberg-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/segmental-specialization-wittenberg-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/segmental-specialization-wittenberg-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/transcriptome-analysis-zhang-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/transcriptome-analysis-zhang-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/transcriptome-analysis-zhang-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/transcriptome-analysis-zhang-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/advances-management-schulman-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/advances-management-schulman-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/advances-management-schulman-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/advances-management-schulman-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-consensus-turpie-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-consensus-turpie-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-consensus-turpie-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-consensus-turpie-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/evolution-comparative-elphick-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/evolution-comparative-elphick-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/evolution-comparative-elphick-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/evolution-comparative-elphick-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/salvage-rates-chang-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/salvage-rates-chang-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/salvage-rates-chang-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/salvage-rates-chang-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/white-light-fox-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/white-light-fox-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/white-light-fox-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/white-light-fox-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulant-therapy-graff-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulant-therapy-graff-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulant-therapy-graff-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulant-therapy-graff-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/endovascular-intervention-virk-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/endovascular-intervention-virk-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/endovascular-intervention-virk-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/endovascular-intervention-virk-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/septicaemia-aeromonas-evans-1990 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/septicaemia-aeromonas-evans-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/septicaemia-aeromonas-evans-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/septicaemia-aeromonas-evans-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/microvascular-free-heffelfinger-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/microvascular-free-heffelfinger-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/microvascular-free-heffelfinger-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/microvascular-free-heffelfinger-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/moving-toward-king-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/moving-toward-king-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/moving-toward-king-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/moving-toward-king-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/distributed-processing-lockery-1990 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/distributed-processing-lockery-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/distributed-processing-lockery-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/distributed-processing-lockery-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/distributed-processing-lockery-1990-2 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/distributed-processing-lockery-1990-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/distributed-processing-lockery-1990-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/distributed-processing-lockery-1990-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/suprastomal-cutaneous-revenaugh-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/suprastomal-cutaneous-revenaugh-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/suprastomal-cutaneous-revenaugh-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/suprastomal-cutaneous-revenaugh-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/transmission-aeromonas-sartor-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/transmission-aeromonas-sartor-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/transmission-aeromonas-sartor-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/transmission-aeromonas-sartor-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/aeromonas-acclimation-richerson-1990 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/aeromonas-acclimation-richerson-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/aeromonas-acclimation-richerson-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/aeromonas-acclimation-richerson-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/evaluation-suspected-roddy-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/evaluation-suspected-roddy-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/evaluation-suspected-roddy-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/evaluation-suspected-roddy-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-beyond-van-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-beyond-van-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-beyond-van-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-beyond-van-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/preparations-hirudo-nikonov-1990 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/preparations-hirudo-nikonov-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/preparations-hirudo-nikonov-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/preparations-hirudo-nikonov-1990 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-acute-ten-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-acute-ten-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-acute-ten-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-acute-ten-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/devices-used-chao-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/devices-used-chao-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/devices-used-chao-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/devices-used-chao-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/advantages-limitations-schulman-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/advantages-limitations-schulman-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/advantages-limitations-schulman-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/advantages-limitations-schulman-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/junction-dependent-baker-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/junction-dependent-baker-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/junction-dependent-baker-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/junction-dependent-baker-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/economic-impact-malik-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/economic-impact-malik-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/economic-impact-malik-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/economic-impact-malik-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/intracellular-recording-titlow-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/intracellular-recording-titlow-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/intracellular-recording-titlow-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/intracellular-recording-titlow-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/antithrombotic-preparations-nikonov-1988 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/antithrombotic-preparations-nikonov-1988 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/antithrombotic-preparations-nikonov-1988 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/antithrombotic-preparations-nikonov-1988 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pharmacologic-characteristics-meddahi-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pharmacologic-characteristics-meddahi-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pharmacologic-characteristics-meddahi-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pharmacologic-characteristics-meddahi-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/predictive-risk-masoomi-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/predictive-risk-masoomi-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/predictive-risk-masoomi-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/predictive-risk-masoomi-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-friedman-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-friedman-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-friedman-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-friedman-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/implantable-cook-um-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/implantable-cook-um-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/implantable-cook-um-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/implantable-cook-um-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/incidence-deep-okuhara-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/incidence-deep-okuhara-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/incidence-deep-okuhara-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/incidence-deep-okuhara-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/current-approaches-chao-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/current-approaches-chao-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/current-approaches-chao-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/current-approaches-chao-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/meta-analysis-nairooz-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/meta-analysis-nairooz-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/meta-analysis-nairooz-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/meta-analysis-nairooz-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/global-coagulation-dinkelaar-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/global-coagulation-dinkelaar-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/global-coagulation-dinkelaar-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/global-coagulation-dinkelaar-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/oral-direct-hillarp-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/oral-direct-hillarp-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/oral-direct-hillarp-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/oral-direct-hillarp-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-versus-cassese-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-versus-cassese-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-versus-cassese-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-versus-cassese-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-versus-cavender-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-versus-cavender-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-versus-cavender-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-versus-cavender-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/drug-induced-kam-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/drug-induced-kam-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/drug-induced-kam-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/drug-induced-kam-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/argatroban-antithrombotic-rozec-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/argatroban-antithrombotic-rozec-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/argatroban-antithrombotic-rozec-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/argatroban-antithrombotic-rozec-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-venous-konstantinides-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-venous-konstantinides-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-venous-konstantinides-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-venous-konstantinides-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-shah-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-shah-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-shah-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-shah-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/laboratory-monitoring-blann-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/laboratory-monitoring-blann-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/laboratory-monitoring-blann-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/laboratory-monitoring-blann-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/association-direct-davidson-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/association-direct-davidson-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/association-direct-davidson-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/association-direct-davidson-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/mechanical-leeching-bank-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/mechanical-leeching-bank-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/mechanical-leeching-bank-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/mechanical-leeching-bank-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/benefit-risk-beyerwestendorf-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/benefit-risk-beyerwestendorf-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/benefit-risk-beyerwestendorf-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/benefit-risk-beyerwestendorf-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-deng-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-deng-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-deng-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-deng-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/multiple-logistic-rao-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/multiple-logistic-rao-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/multiple-logistic-rao-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/multiple-logistic-rao-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/changing-practice-arepally-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/changing-practice-arepally-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/changing-practice-arepally-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/changing-practice-arepally-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-inferior-huang-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-inferior-huang-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-inferior-huang-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-inferior-huang-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/free-flap-chen-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/free-flap-chen-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/free-flap-chen-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/free-flap-chen-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/early-stent-piccolo-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/early-stent-piccolo-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/early-stent-piccolo-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/early-stent-piccolo-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/peripherally-inserted-fallouh-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/peripherally-inserted-fallouh-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/peripherally-inserted-fallouh-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/peripherally-inserted-fallouh-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-factor-ma-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-factor-ma-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-factor-ma-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-factor-ma-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/recurrent-venous-schulman-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/recurrent-venous-schulman-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/recurrent-venous-schulman-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/recurrent-venous-schulman-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/safety-efficacy-noel-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/safety-efficacy-noel-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/safety-efficacy-noel-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/safety-efficacy-noel-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulants-management-piovella-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulants-management-piovella-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulants-management-piovella-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulants-management-piovella-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/short-long-nairooz-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/short-long-nairooz-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/short-long-nairooz-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/short-long-nairooz-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-adjunctive-mcnair-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-adjunctive-mcnair-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-adjunctive-mcnair-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-adjunctive-mcnair-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/critical-appraisal-bavry-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/critical-appraisal-bavry-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/critical-appraisal-bavry-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/critical-appraisal-bavry-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/results-free-kim-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/results-free-kim-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/results-free-kim-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/results-free-kim-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/current-emerging-fanola-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/current-emerging-fanola-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/current-emerging-fanola-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/current-emerging-fanola-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-strategies-black-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-strategies-black-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-strategies-black-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-strategies-black-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/microvascular-reconstruction-cannady-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/microvascular-reconstruction-cannady-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/microvascular-reconstruction-cannady-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/microvascular-reconstruction-cannady-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/observational-factor-spiller-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/observational-factor-spiller-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/observational-factor-spiller-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/observational-factor-spiller-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-sanidas-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-sanidas-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-sanidas-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-sanidas-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-deep-messas-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-deep-messas-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-deep-messas-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-deep-messas-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/monitoring-microvascular-just-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/monitoring-microvascular-just-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/monitoring-microvascular-just-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/monitoring-microvascular-just-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/andexanet-alfa-siegal-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/andexanet-alfa-siegal-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/andexanet-alfa-siegal-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/andexanet-alfa-siegal-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/factors-affecting-bittl-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/factors-affecting-bittl-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/factors-affecting-bittl-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/factors-affecting-bittl-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/goal-directed-funk-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/goal-directed-funk-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/goal-directed-funk-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/goal-directed-funk-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-versus-faulkenberg-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-versus-faulkenberg-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-versus-faulkenberg-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-versus-faulkenberg-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/updated-comprehensive-shah-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/updated-comprehensive-shah-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/updated-comprehensive-shah-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/updated-comprehensive-shah-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-chao-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-chao-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-chao-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-chao-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficacy-safety-zhang-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficacy-safety-zhang-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficacy-safety-zhang-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficacy-safety-zhang-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/approaches-thrombin-estevepastor-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/approaches-thrombin-estevepastor-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/approaches-thrombin-estevepastor-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/approaches-thrombin-estevepastor-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-factor-bonar-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-factor-bonar-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-factor-bonar-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-factor-bonar-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/rivaroxaban-treatment-linkins-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/rivaroxaban-treatment-linkins-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/rivaroxaban-treatment-linkins-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/rivaroxaban-treatment-linkins-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-recurrent-romualdi-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-recurrent-romualdi-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-recurrent-romualdi-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-recurrent-romualdi-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/oral-anticoagulants-skelley-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/oral-anticoagulants-skelley-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/oral-anticoagulants-skelley-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/oral-anticoagulants-skelley-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/treat-patients-warkentin-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/treat-patients-warkentin-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/treat-patients-warkentin-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/treat-patients-warkentin-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-versus-mahmoud-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-versus-mahmoud-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-versus-mahmoud-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-versus-mahmoud-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hospital-management-lenchus-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hospital-management-lenchus-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hospital-management-lenchus-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hospital-management-lenchus-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulant-activity-maraganore-1989 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulant-activity-maraganore-1989 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulant-activity-maraganore-1989 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulant-activity-maraganore-1989 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-considerations-moulder-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-considerations-moulder-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-considerations-moulder-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-considerations-moulder-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/microvascular-reconstruction-hayashi-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/microvascular-reconstruction-hayashi-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/microvascular-reconstruction-hayashi-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/microvascular-reconstruction-hayashi-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/algorithmic-approach-dhakal-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/algorithmic-approach-dhakal-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/algorithmic-approach-dhakal-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/algorithmic-approach-dhakal-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/post-primary-shah-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/post-primary-shah-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/post-primary-shah-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/post-primary-shah-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/transradial-access-pasala-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/transradial-access-pasala-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/transradial-access-pasala-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/transradial-access-pasala-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prolonged-high-fahrni-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prolonged-high-fahrni-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prolonged-high-fahrni-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prolonged-high-fahrni-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/small-cardioactive-evans-1989 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/small-cardioactive-evans-1989 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/small-cardioactive-evans-1989 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/small-cardioactive-evans-1989 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-yeo-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-yeo-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-yeo-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-yeo-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pump-interacts-kueh-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pump-interacts-kueh-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pump-interacts-kueh-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pump-interacts-kueh-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/perioperative-deep-sinha-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/perioperative-deep-sinha-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/perioperative-deep-sinha-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/perioperative-deep-sinha-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/combination-prophylaxis-lin-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/combination-prophylaxis-lin-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/combination-prophylaxis-lin-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/combination-prophylaxis-lin-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/incidence-deep-konoeda-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/incidence-deep-konoeda-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/incidence-deep-konoeda-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/incidence-deep-konoeda-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-venous-barbui-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-venous-barbui-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-venous-barbui-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-venous-barbui-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-riedel-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-riedel-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-riedel-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-riedel-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/ischaemic-colitis-trotter-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/ischaemic-colitis-trotter-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/ischaemic-colitis-trotter-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/ischaemic-colitis-trotter-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/mobile-pump-haynes-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/mobile-pump-haynes-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/mobile-pump-haynes-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/mobile-pump-haynes-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-versus-xu-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-versus-xu-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-versus-xu-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-versus-xu-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/current-techniques-khatri-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/current-techniques-khatri-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/current-techniques-khatri-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/current-techniques-khatri-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-versus-saad-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-versus-saad-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-versus-saad-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-versus-saad-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/emerging-direct-tran-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/emerging-direct-tran-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/emerging-direct-tran-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/emerging-direct-tran-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-patients-huber-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-patients-huber-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-patients-huber-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-patients-huber-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-saleh-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-saleh-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-saleh-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-saleh-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/therapeutic-protein-asgari-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/therapeutic-protein-asgari-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/therapeutic-protein-asgari-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/therapeutic-protein-asgari-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/utility-hemoccult-urbas-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/utility-hemoccult-urbas-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/utility-hemoccult-urbas-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/utility-hemoccult-urbas-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/international-normalized-ofek-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/international-normalized-ofek-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/international-normalized-ofek-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/international-normalized-ofek-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/phenanthrol-modulates-angstadt-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/phenanthrol-modulates-angstadt-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/phenanthrol-modulates-angstadt-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/phenanthrol-modulates-angstadt-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-lim-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-lim-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-lim-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-lim-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-acting-davis-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-acting-davis-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-acting-davis-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-acting-davis-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/down-atmospheric-hsu-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/down-atmospheric-hsu-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/down-atmospheric-hsu-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/down-atmospheric-hsu-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-frank-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-frank-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-frank-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-frank-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficacy-safety-zhang-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficacy-safety-zhang-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficacy-safety-zhang-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficacy-safety-zhang-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/measuring-direct-gosselin-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/measuring-direct-gosselin-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/measuring-direct-gosselin-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/measuring-direct-gosselin-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-treatment-hunter-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-treatment-hunter-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-treatment-hunter-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-treatment-hunter-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-factor-milling-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-factor-milling-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-factor-milling-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-factor-milling-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/risk-deep-ganau-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/risk-deep-ganau-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/risk-deep-ganau-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/risk-deep-ganau-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/postoperative-skin-lucht-1988 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/postoperative-skin-lucht-1988 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/postoperative-skin-lucht-1988 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/postoperative-skin-lucht-1988 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/controversies-microvascular-fagin-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/controversies-microvascular-fagin-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/controversies-microvascular-fagin-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/controversies-microvascular-fagin-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/dilemmas-management-shakeel-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/dilemmas-management-shakeel-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/dilemmas-management-shakeel-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/dilemmas-management-shakeel-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/fondaparinux-treatment-warkentin-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/fondaparinux-treatment-warkentin-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/fondaparinux-treatment-warkentin-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/fondaparinux-treatment-warkentin-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/evaluation-implantable-lenz-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/evaluation-implantable-lenz-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/evaluation-implantable-lenz-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/evaluation-implantable-lenz-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/risk-incidence-osaki-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/risk-incidence-osaki-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/risk-incidence-osaki-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/risk-incidence-osaki-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/interventional-spine-narouze-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/interventional-spine-narouze-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/interventional-spine-narouze-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/interventional-spine-narouze-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-horner-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-horner-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-horner-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-horner-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-edwards-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-edwards-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-edwards-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-edwards-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/total-lower-cakmak-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/total-lower-cakmak-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/total-lower-cakmak-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/total-lower-cakmak-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/responses-mechanically-lehmkuhl-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/responses-mechanically-lehmkuhl-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/responses-mechanically-lehmkuhl-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/responses-mechanically-lehmkuhl-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/preoperative-deep-pandey-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/preoperative-deep-pandey-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/preoperative-deep-pandey-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/preoperative-deep-pandey-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anti-activity-samos-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anti-activity-samos-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anti-activity-samos-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anti-activity-samos-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/exploration-bivalirudin-li-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/exploration-bivalirudin-li-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/exploration-bivalirudin-li-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/exploration-bivalirudin-li-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-lieberman-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-lieberman-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-lieberman-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-lieberman-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-therapy-yamashita-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-therapy-yamashita-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-therapy-yamashita-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-therapy-yamashita-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/great-debates-kanthi-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/great-debates-kanthi-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/great-debates-kanthi-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/great-debates-kanthi-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/skin-paddles-stranix-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/skin-paddles-stranix-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/skin-paddles-stranix-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/skin-paddles-stranix-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/sharing-experience-yannoutsos-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/sharing-experience-yannoutsos-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/sharing-experience-yannoutsos-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/sharing-experience-yannoutsos-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pharmacology-oral-jain-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pharmacology-oral-jain-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pharmacology-oral-jain-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pharmacology-oral-jain-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-versus-venetsanos-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-versus-venetsanos-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-versus-venetsanos-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-versus-venetsanos-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/andexanet-alfa-heo-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/andexanet-alfa-heo-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/andexanet-alfa-heo-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/andexanet-alfa-heo-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/annotated-transcriptome-northcutt-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/annotated-transcriptome-northcutt-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/annotated-transcriptome-northcutt-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/annotated-transcriptome-northcutt-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/incidence-deep-chang-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/incidence-deep-chang-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/incidence-deep-chang-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/incidence-deep-chang-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/rivaroxaban-apixaban-carter-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/rivaroxaban-apixaban-carter-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/rivaroxaban-apixaban-carter-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/rivaroxaban-apixaban-carter-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/update-anticoagulant-van-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/update-anticoagulant-van-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/update-anticoagulant-van-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/update-anticoagulant-van-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-vein-shaikhouni-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-vein-shaikhouni-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-vein-shaikhouni-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-vein-shaikhouni-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-venous-lopeznunez-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-venous-lopeznunez-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-venous-lopeznunez-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-venous-lopeznunez-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anti-oral-billoir-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anti-oral-billoir-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anti-oral-billoir-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anti-oral-billoir-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/graduated-compression-sachdeva-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/graduated-compression-sachdeva-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/graduated-compression-sachdeva-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/graduated-compression-sachdeva-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/saliva-medicinal-rigbi-1987 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/saliva-medicinal-rigbi-1987 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/saliva-medicinal-rigbi-1987 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/saliva-medicinal-rigbi-1987 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/treatment-apixaban-sheikhtaha-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/treatment-apixaban-sheikhtaha-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/treatment-apixaban-sheikhtaha-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/treatment-apixaban-sheikhtaha-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/postoperative-major-wong-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/postoperative-major-wong-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/postoperative-major-wong-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/postoperative-major-wong-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/american-society-witt-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/american-society-witt-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/american-society-witt-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/american-society-witt-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/laboratorieanalyser-noak-strandberg-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/laboratorieanalyser-noak-strandberg-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/laboratorieanalyser-noak-strandberg-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/laboratorieanalyser-noak-strandberg-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/free-flap-van-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/free-flap-van-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/free-flap-van-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/free-flap-van-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/lessons-learned-in-the-woo-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/lessons-learned-in-the-woo-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/lessons-learned-in-the-woo-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/lessons-learned-in-the-woo-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bedside-monitoring-of-free-adelsberger-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bedside-monitoring-of-free-adelsberger-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bedside-monitoring-of-free-adelsberger-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bedside-monitoring-of-free-adelsberger-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/an-anticoagulant-peptide-from-liu-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/an-anticoagulant-peptide-from-liu-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/an-anticoagulant-peptide-from-liu-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/an-anticoagulant-peptide-from-liu-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/outcomes-following-replantation-revascularization-in-cho-201 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/outcomes-following-replantation-revascularization-in-cho-201 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/outcomes-following-replantation-revascularization-in-cho-201 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/outcomes-following-replantation-revascularization-in-cho-201 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/fluorescent-indocyanine-green-angiography-moris-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/fluorescent-indocyanine-green-angiography-moris-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/fluorescent-indocyanine-green-angiography-moris-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/fluorescent-indocyanine-green-angiography-moris-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/inpatient-flap-monitoring-after-carruthers-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/inpatient-flap-monitoring-after-carruthers-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/inpatient-flap-monitoring-after-carruthers-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/inpatient-flap-monitoring-after-carruthers-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/outcomes-of-free-flap-newton-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/outcomes-of-free-flap-newton-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/outcomes-of-free-flap-newton-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/outcomes-of-free-flap-newton-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/practical-tips-to-improve-woo-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/practical-tips-to-improve-woo-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/practical-tips-to-improve-woo-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/practical-tips-to-improve-woo-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/mechanism-and-inhibition-kinetics-chen-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/mechanism-and-inhibition-kinetics-chen-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/mechanism-and-inhibition-kinetics-chen-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/mechanism-and-inhibition-kinetics-chen-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/finger-and-thumb-replantation-barbato-2019 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/finger-and-thumb-replantation-barbato-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/finger-and-thumb-replantation-barbato-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/finger-and-thumb-replantation-barbato-2019 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/retrograde-versus-anterograde-palm-liu-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/retrograde-versus-anterograde-palm-liu-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/retrograde-versus-anterograde-palm-liu-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/retrograde-versus-anterograde-palm-liu-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/microvascular-replantation-of-totally-jiang-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/microvascular-replantation-of-totally-jiang-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/microvascular-replantation-of-totally-jiang-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/microvascular-replantation-of-totally-jiang-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/free-flap-monitoring-review-and-lovx11btxednskxe1-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/free-flap-monitoring-review-and-lovx11btxednskxe1-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/free-flap-monitoring-review-and-lovx11btxednskxe1-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/free-flap-monitoring-review-and-lovx11btxednskxe1-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/targeted-inhibition-of-activated-zhao-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/targeted-inhibition-of-activated-zhao-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/targeted-inhibition-of-activated-zhao-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/targeted-inhibition-of-activated-zhao-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/treatment-of-multiple-digit-takeda-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/treatment-of-multiple-digit-takeda-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/treatment-of-multiple-digit-takeda-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/treatment-of-multiple-digit-takeda-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/aesthetic-functional-reconstruction-of-hu-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/aesthetic-functional-reconstruction-of-hu-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/aesthetic-functional-reconstruction-of-hu-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/aesthetic-functional-reconstruction-of-hu-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/leech-extract-a-candidate-wang-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/leech-extract-a-candidate-wang-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/leech-extract-a-candidate-wang-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/leech-extract-a-candidate-wang-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/an-enemy-after-bartochowska-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/an-enemy-after-bartochowska-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/an-enemy-after-bartochowska-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/an-enemy-after-bartochowska-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/dabigatran-use-after-argatroban-wang-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/dabigatran-use-after-argatroban-wang-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/dabigatran-use-after-argatroban-wang-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/dabigatran-use-after-argatroban-wang-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/gfht-proposals-on-the-siguret-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/gfht-proposals-on-the-siguret-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/gfht-proposals-on-the-siguret-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/gfht-proposals-on-the-siguret-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-rare-case-of-greiner-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-rare-case-of-greiner-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-rare-case-of-greiner-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-rare-case-of-greiner-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/rivaroxaban-and-apixaban-for-cirbus-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/rivaroxaban-and-apixaban-for-cirbus-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/rivaroxaban-and-apixaban-for-cirbus-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/rivaroxaban-and-apixaban-for-cirbus-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/use-of-argatroban-in-sharif-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/use-of-argatroban-in-sharif-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/use-of-argatroban-in-sharif-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/use-of-argatroban-in-sharif-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/dna-barcoding-molecular-identification-hussain-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/dna-barcoding-molecular-identification-hussain-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/dna-barcoding-molecular-identification-hussain-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/dna-barcoding-molecular-identification-hussain-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/breaking-the-technical-barrier-bao-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/breaking-the-technical-barrier-bao-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/breaking-the-technical-barrier-bao-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/breaking-the-technical-barrier-bao-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bactericidal-efficacy-of-non-thermal-kim-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bactericidal-efficacy-of-non-thermal-kim-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bactericidal-efficacy-of-non-thermal-kim-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bactericidal-efficacy-of-non-thermal-kim-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-72-hour-microcirculation-dynamics-moellhoff-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-72-hour-microcirculation-dynamics-moellhoff-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-72-hour-microcirculation-dynamics-moellhoff-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-72-hour-microcirculation-dynamics-moellhoff-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/outcomes-of-anastomotic-venous-bowe-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/outcomes-of-anastomotic-venous-bowe-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/outcomes-of-anastomotic-venous-bowe-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/outcomes-of-anastomotic-venous-bowe-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/atrial-fibrillation-in-a-sakai-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/atrial-fibrillation-in-a-sakai-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/atrial-fibrillation-in-a-sakai-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/atrial-fibrillation-in-a-sakai-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/managing-argatroban-in-heparin-induced-marchetti-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/managing-argatroban-in-heparin-induced-marchetti-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/managing-argatroban-in-heparin-induced-marchetti-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/managing-argatroban-in-heparin-induced-marchetti-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-present-state-of-atkauskien-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-present-state-of-atkauskien-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-present-state-of-atkauskien-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-present-state-of-atkauskien-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/how-to-dose-and-warkentin-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/how-to-dose-and-warkentin-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/how-to-dose-and-warkentin-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/how-to-dose-and-warkentin-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-genomic-island-of-herrera-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-genomic-island-of-herrera-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-genomic-island-of-herrera-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-genomic-island-of-herrera-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/polyethylene-microplastic-exposure-and-ding-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/polyethylene-microplastic-exposure-and-ding-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/polyethylene-microplastic-exposure-and-ding-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/polyethylene-microplastic-exposure-and-ding-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/post-operative-monitoring-for-head-anagnos-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/post-operative-monitoring-for-head-anagnos-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/post-operative-monitoring-for-head-anagnos-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/post-operative-monitoring-for-head-anagnos-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/vitamin-d-ameliorates-aeromonas-sun-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/vitamin-d-ameliorates-aeromonas-sun-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/vitamin-d-ameliorates-aeromonas-sun-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/vitamin-d-ameliorates-aeromonas-sun-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/unlocking-the-potential-of-wang-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/unlocking-the-potential-of-wang-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/unlocking-the-potential-of-wang-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/unlocking-the-potential-of-wang-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/adjunctive-technologies-in-postoperative-lacey-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/adjunctive-technologies-in-postoperative-lacey-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/adjunctive-technologies-in-postoperative-lacey-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/adjunctive-technologies-in-postoperative-lacey-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/autoimmune-heparin-induced-thrombocytopenia-warkentin-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/autoimmune-heparin-induced-thrombocytopenia-warkentin-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/autoimmune-heparin-induced-thrombocytopenia-warkentin-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/autoimmune-heparin-induced-thrombocytopenia-warkentin-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prospection-of-peptide-inhibitors-balakrishnan-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prospection-of-peptide-inhibitors-balakrishnan-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prospection-of-peptide-inhibitors-balakrishnan-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prospection-of-peptide-inhibitors-balakrishnan-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/intraoperative-argatroban-vessel-irrigation-habibi-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/intraoperative-argatroban-vessel-irrigation-habibi-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/intraoperative-argatroban-vessel-irrigation-habibi-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/intraoperative-argatroban-vessel-irrigation-habibi-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-impact-of-venous-rao-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-impact-of-venous-rao-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-impact-of-venous-rao-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-impact-of-venous-rao-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/unusual-case-of-bilateral-ax11fx131n-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/unusual-case-of-bilateral-ax11fx131n-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/unusual-case-of-bilateral-ax11fx131n-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/unusual-case-of-bilateral-ax11fx131n-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/perioperative-plasma-exchange-and-habibi-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/perioperative-plasma-exchange-and-habibi-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/perioperative-plasma-exchange-and-habibi-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/perioperative-plasma-exchange-and-habibi-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/microsurgical-digits-replantation-in-altam-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/microsurgical-digits-replantation-in-altam-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/microsurgical-digits-replantation-in-altam-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/microsurgical-digits-replantation-in-altam-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-of-heparin-induced-thrombocytopenia-gxf3mezalonso 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-of-heparin-induced-thrombocytopenia-gxf3mezalonso 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-of-heparin-induced-thrombocytopenia-gxf3mezalonso 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-of-heparin-induced-thrombocytopenia-gxf3mezalonso 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/proteomic-analysis-of-crocodile-tankrathok-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/proteomic-analysis-of-crocodile-tankrathok-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/proteomic-analysis-of-crocodile-tankrathok-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/proteomic-analysis-of-crocodile-tankrathok-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-presence-of-four-lin-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-presence-of-four-lin-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-presence-of-four-lin-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-presence-of-four-lin-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/replantation-of-digit-tip-amputation-peng-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/replantation-of-digit-tip-amputation-peng-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/replantation-of-digit-tip-amputation-peng-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/replantation-of-digit-tip-amputation-peng-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/acanthopanax-senticosus-cultures-fermented-ma-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/acanthopanax-senticosus-cultures-fermented-ma-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/acanthopanax-senticosus-cultures-fermented-ma-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/acanthopanax-senticosus-cultures-fermented-ma-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/construction-of-an-aerolysin-based-alawam-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/construction-of-an-aerolysin-based-alawam-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/construction-of-an-aerolysin-based-alawam-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/construction-of-an-aerolysin-based-alawam-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-novel-data-fusion-song-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-novel-data-fusion-song-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-novel-data-fusion-song-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-novel-data-fusion-song-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/leech-therapy-for-venous-bhatt-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/leech-therapy-for-venous-bhatt-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/leech-therapy-for-venous-bhatt-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/leech-therapy-for-venous-bhatt-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/clinical-presentation-antimicrobial-resistance-pinedareyes-2 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/clinical-presentation-antimicrobial-resistance-pinedareyes-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/clinical-presentation-antimicrobial-resistance-pinedareyes-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/clinical-presentation-antimicrobial-resistance-pinedareyes-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-fatal-case-of-yonezu-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-fatal-case-of-yonezu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-fatal-case-of-yonezu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-fatal-case-of-yonezu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/use-of-bivalirudin-for-branstetter-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/use-of-bivalirudin-for-branstetter-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/use-of-bivalirudin-for-branstetter-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/use-of-bivalirudin-for-branstetter-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prolonged-use-of-extracorporeal-ox11fux15f-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prolonged-use-of-extracorporeal-ox11fux15f-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prolonged-use-of-extracorporeal-ox11fux15f-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prolonged-use-of-extracorporeal-ox11fux15f-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/is-bivalirudin-efficacious-in-valecha-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/is-bivalirudin-efficacious-in-valecha-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/is-bivalirudin-efficacious-in-valecha-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/is-bivalirudin-efficacious-in-valecha-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficient-replantation-techniques-tricks-martins-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficient-replantation-techniques-tricks-martins-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficient-replantation-techniques-tricks-martins-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficient-replantation-techniques-tricks-martins-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/independent-and-interactive-roles-li-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/independent-and-interactive-roles-li-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/independent-and-interactive-roles-li-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/independent-and-interactive-roles-li-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/chemical-composition-analysis-of-lu-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/chemical-composition-analysis-of-lu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/chemical-composition-analysis-of-lu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/chemical-composition-analysis-of-lu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/preliminary-insights-into-monitoring-yates-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/preliminary-insights-into-monitoring-yates-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/preliminary-insights-into-monitoring-yates-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/preliminary-insights-into-monitoring-yates-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/antibiotic-resistance-profiles-of-michel-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/antibiotic-resistance-profiles-of-michel-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/antibiotic-resistance-profiles-of-michel-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/antibiotic-resistance-profiles-of-michel-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/proteolytic-signatures-of-coagulation-delcastilloalferez-202 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/proteolytic-signatures-of-coagulation-delcastilloalferez-202 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/proteolytic-signatures-of-coagulation-delcastilloalferez-202 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/proteolytic-signatures-of-coagulation-delcastilloalferez-202 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-inhibits-ferroptosis-to-lan-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-inhibits-ferroptosis-to-lan-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-inhibits-ferroptosis-to-lan-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-inhibits-ferroptosis-to-lan-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-versus-heparin-in-alqawasmi-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-versus-heparin-in-alqawasmi-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-versus-heparin-in-alqawasmi-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-versus-heparin-in-alqawasmi-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparative-analysis-of-thrombosis-cho-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparative-analysis-of-thrombosis-cho-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparative-analysis-of-thrombosis-cho-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparative-analysis-of-thrombosis-cho-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/construction-of-safer-hirudin-derived-yi-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/construction-of-safer-hirudin-derived-yi-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/construction-of-safer-hirudin-derived-yi-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/construction-of-safer-hirudin-derived-yi-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-oral-anticoagulants-versus-ruizartacho-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-oral-anticoagulants-versus-ruizartacho-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-oral-anticoagulants-versus-ruizartacho-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-oral-anticoagulants-versus-ruizartacho-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/activated-partial-thromboplastin-time-burx161a-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/activated-partial-thromboplastin-time-burx161a-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/activated-partial-thromboplastin-time-burx161a-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/activated-partial-thromboplastin-time-burx161a-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/unusual-presentation-of-heparin-induced-zakhour-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/unusual-presentation-of-heparin-induced-zakhour-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/unusual-presentation-of-heparin-induced-zakhour-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/unusual-presentation-of-heparin-induced-zakhour-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-alleviates-early-brain-pan-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-alleviates-early-brain-pan-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-alleviates-early-brain-pan-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-alleviates-early-brain-pan-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/clinical-characteristics-and-antibiotic-liu-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/clinical-characteristics-and-antibiotic-liu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/clinical-characteristics-and-antibiotic-liu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/clinical-characteristics-and-antibiotic-liu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparative-risk-of-nonvertebral-zeng-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparative-risk-of-nonvertebral-zeng-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparative-risk-of-nonvertebral-zeng-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparative-risk-of-nonvertebral-zeng-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/nanostructured-scaffold-combined-with-marcolli-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/nanostructured-scaffold-combined-with-marcolli-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/nanostructured-scaffold-combined-with-marcolli-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/nanostructured-scaffold-combined-with-marcolli-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/considerations-of-safety-for-butler-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/considerations-of-safety-for-butler-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/considerations-of-safety-for-butler-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/considerations-of-safety-for-butler-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/primary-anticoagulation-with-bivalirudin-gramegna-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/primary-anticoagulation-with-bivalirudin-gramegna-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/primary-anticoagulation-with-bivalirudin-gramegna-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/primary-anticoagulation-with-bivalirudin-gramegna-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-treatment-and-holubar-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-treatment-and-holubar-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-treatment-and-holubar-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-treatment-and-holubar-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/ecarin-based-coagulation-monitoring-of-schiferer-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/ecarin-based-coagulation-monitoring-of-schiferer-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/ecarin-based-coagulation-monitoring-of-schiferer-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/ecarin-based-coagulation-monitoring-of-schiferer-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/retrospective-cohort-analysis-of-chang-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/retrospective-cohort-analysis-of-chang-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/retrospective-cohort-analysis-of-chang-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/retrospective-cohort-analysis-of-chang-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/associations-between-fracture-characteristics-kageyama-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/associations-between-fracture-characteristics-kageyama-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/associations-between-fracture-characteristics-kageyama-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/associations-between-fracture-characteristics-kageyama-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-promotes-peripheral-nerve-wu-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-promotes-peripheral-nerve-wu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-promotes-peripheral-nerve-wu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-promotes-peripheral-nerve-wu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/individualizing-thromboprophylaxis-from-fixed-kotsiou-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/individualizing-thromboprophylaxis-from-fixed-kotsiou-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/individualizing-thromboprophylaxis-from-fixed-kotsiou-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/individualizing-thromboprophylaxis-from-fixed-kotsiou-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/apixaban-versus-enoxaparin-for-miratashiyazdi-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/apixaban-versus-enoxaparin-for-miratashiyazdi-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/apixaban-versus-enoxaparin-for-miratashiyazdi-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/apixaban-versus-enoxaparin-for-miratashiyazdi-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/evaluation-of-re-used-medicinal-soula-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/evaluation-of-re-used-medicinal-soula-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/evaluation-of-re-used-medicinal-soula-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/evaluation-of-re-used-medicinal-soula-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/argatroban-for-intraoperative-anticoagulation-eappen-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/argatroban-for-intraoperative-anticoagulation-eappen-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/argatroban-for-intraoperative-anticoagulation-eappen-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/argatroban-for-intraoperative-anticoagulation-eappen-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/alternative-anticoagulation-for-patients-unicstojanovic-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/alternative-anticoagulation-for-patients-unicstojanovic-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/alternative-anticoagulation-for-patients-unicstojanovic-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/alternative-anticoagulation-for-patients-unicstojanovic-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficacy-of-infrared-thermographic-thyagaraj-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficacy-of-infrared-thermographic-thyagaraj-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficacy-of-infrared-thermographic-thyagaraj-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficacy-of-infrared-thermographic-thyagaraj-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/tissue-regenerative-potential-of-marcolli-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/tissue-regenerative-potential-of-marcolli-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/tissue-regenerative-potential-of-marcolli-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/tissue-regenerative-potential-of-marcolli-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/increased-incidence-of-thrombosis-becher-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/increased-incidence-of-thrombosis-becher-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/increased-incidence-of-thrombosis-becher-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/increased-incidence-of-thrombosis-becher-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/beyond-activated-partial-thromboplastin-gratz-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/beyond-activated-partial-thromboplastin-gratz-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/beyond-activated-partial-thromboplastin-gratz-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/beyond-activated-partial-thromboplastin-gratz-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/minimal-intraoperative-anticoagulation-strategy-bagrodia-202 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/minimal-intraoperative-anticoagulation-strategy-bagrodia-202 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/minimal-intraoperative-anticoagulation-strategy-bagrodia-202 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/minimal-intraoperative-anticoagulation-strategy-bagrodia-202 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/beyond-the-flare-a-ramxedrezolivencia-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/beyond-the-flare-a-ramxedrezolivencia-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/beyond-the-flare-a-ramxedrezolivencia-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/beyond-the-flare-a-ramxedrezolivencia-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/impact-of-cystatin-c-wieruszewski-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/impact-of-cystatin-c-wieruszewski-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/impact-of-cystatin-c-wieruszewski-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/impact-of-cystatin-c-wieruszewski-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bleeding-risk-with-apixaban-castellucci-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bleeding-risk-with-apixaban-castellucci-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bleeding-risk-with-apixaban-castellucci-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bleeding-risk-with-apixaban-castellucci-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficacy-and-safety-of-brown-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficacy-and-safety-of-brown-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficacy-and-safety-of-brown-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficacy-and-safety-of-brown-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/extended-thromboprophylaxis-after-hip-clavijo-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/extended-thromboprophylaxis-after-hip-clavijo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/extended-thromboprophylaxis-after-hip-clavijo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/extended-thromboprophylaxis-after-hip-clavijo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-monitoring-using-dilute-dorn-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-monitoring-using-dilute-dorn-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-monitoring-using-dilute-dorn-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-monitoring-using-dilute-dorn-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/is-low-dose-aspirin-the-tummala-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/is-low-dose-aspirin-the-tummala-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/is-low-dose-aspirin-the-tummala-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/is-low-dose-aspirin-the-tummala-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/acute-unintentional-single-substance-pediatric-kolbeck-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/acute-unintentional-single-substance-pediatric-kolbeck-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/acute-unintentional-single-substance-pediatric-kolbeck-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/acute-unintentional-single-substance-pediatric-kolbeck-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/safety-of-prothrombin-complex-eshaghpour-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/safety-of-prothrombin-complex-eshaghpour-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/safety-of-prothrombin-complex-eshaghpour-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/safety-of-prothrombin-complex-eshaghpour-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/medicinal-leech-therapy-in-itankar-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/medicinal-leech-therapy-in-itankar-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/medicinal-leech-therapy-in-itankar-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/medicinal-leech-therapy-in-itankar-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hematologic-adverse-events-following-smolinski-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hematologic-adverse-events-following-smolinski-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hematologic-adverse-events-following-smolinski-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hematologic-adverse-events-following-smolinski-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/advancing-point-of-care-analysis-the-herpertz-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/advancing-point-of-care-analysis-the-herpertz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/advancing-point-of-care-analysis-the-herpertz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/advancing-point-of-care-analysis-the-herpertz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/safety-and-efficacy-of-kumar-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/safety-and-efficacy-of-kumar-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/safety-and-efficacy-of-kumar-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/safety-and-efficacy-of-kumar-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/patient-perspectives-on-post-operative-black-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/patient-perspectives-on-post-operative-black-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/patient-perspectives-on-post-operative-black-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/patient-perspectives-on-post-operative-black-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bioinspired-apixaban-nanosuspension-loaded-polymeric-abdelme 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bioinspired-apixaban-nanosuspension-loaded-polymeric-abdelme 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bioinspired-apixaban-nanosuspension-loaded-polymeric-abdelme 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bioinspired-apixaban-nanosuspension-loaded-polymeric-abdelme 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/systematic-review-on-the-whitworth-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/systematic-review-on-the-whitworth-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/systematic-review-on-the-whitworth-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/systematic-review-on-the-whitworth-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/factor-xi-inhibitors-in-falama-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/factor-xi-inhibitors-in-falama-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/factor-xi-inhibitors-in-falama-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/factor-xi-inhibitors-in-falama-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparative-effectiveness-of-oral-park-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparative-effectiveness-of-oral-park-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparative-effectiveness-of-oral-park-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparative-effectiveness-of-oral-park-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/antithrombin-and-heparin-cofactor-gracher-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/antithrombin-and-heparin-cofactor-gracher-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/antithrombin-and-heparin-cofactor-gracher-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/antithrombin-and-heparin-cofactor-gracher-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/strategies-to-ensure-success-gardiner-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/strategies-to-ensure-success-gardiner-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/strategies-to-ensure-success-gardiner-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/strategies-to-ensure-success-gardiner-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/atorvastatin-has-antithrombotic-effects-tehrani-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/atorvastatin-has-antithrombotic-effects-tehrani-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/atorvastatin-has-antithrombotic-effects-tehrani-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/atorvastatin-has-antithrombotic-effects-tehrani-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/identification-of-an-antithrombotic-dowal-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/identification-of-an-antithrombotic-dowal-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/identification-of-an-antithrombotic-dowal-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/identification-of-an-antithrombotic-dowal-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/tissue-oximetry-monitoring-in-lin-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/tissue-oximetry-monitoring-in-lin-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/tissue-oximetry-monitoring-in-lin-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/tissue-oximetry-monitoring-in-lin-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-common-standard-is-jeske-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-common-standard-is-jeske-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-common-standard-is-jeske-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-common-standard-is-jeske-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-use-of-visible-cornejo-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-use-of-visible-cornejo-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-use-of-visible-cornejo-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-use-of-visible-cornejo-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/new-targets-for-anticoagulation-ansell-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/new-targets-for-anticoagulation-ansell-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/new-targets-for-anticoagulation-ansell-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/new-targets-for-anticoagulation-ansell-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulant-anti-aggregation-and-antithrombotic-long-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulant-anti-aggregation-and-antithrombotic-long-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulant-anti-aggregation-and-antithrombotic-long-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulant-anti-aggregation-and-antithrombotic-long-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-new-function-for-su-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-new-function-for-su-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-new-function-for-su-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-new-function-for-su-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-new-peptide-ruviprase-thakur-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-new-peptide-ruviprase-thakur-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-new-peptide-ruviprase-thakur-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-new-peptide-ruviprase-thakur-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/lx0702-a-novel-snake-kong-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/lx0702-a-novel-snake-kong-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/lx0702-a-novel-snake-kong-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/lx0702-a-novel-snake-kong-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/antiplatelet-and-antithrombotic-activity-majumdar-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/antiplatelet-and-antithrombotic-activity-majumdar-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/antiplatelet-and-antithrombotic-activity-majumdar-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/antiplatelet-and-antithrombotic-activity-majumdar-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/species-of-apatemon-szidat-blascocosta-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/species-of-apatemon-szidat-blascocosta-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/species-of-apatemon-szidat-blascocosta-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/species-of-apatemon-szidat-blascocosta-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/solving-a-bloody-mess-manzanomarxedn-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/solving-a-bloody-mess-manzanomarxedn-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/solving-a-bloody-mess-manzanomarxedn-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/solving-a-bloody-mess-manzanomarxedn-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/free-tissue-transfer-in-allami-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/free-tissue-transfer-in-allami-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/free-tissue-transfer-in-allami-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/free-tissue-transfer-in-allami-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/outcomes-of-take-back-operations-yim-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/outcomes-of-take-back-operations-yim-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/outcomes-of-take-back-operations-yim-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/outcomes-of-take-back-operations-yim-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/in-vitro-antithrombotic-activities-zhang-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/in-vitro-antithrombotic-activities-zhang-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/in-vitro-antithrombotic-activities-zhang-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/in-vitro-antithrombotic-activities-zhang-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/is-the-preoperative-mpv-eser-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/is-the-preoperative-mpv-eser-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/is-the-preoperative-mpv-eser-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/is-the-preoperative-mpv-eser-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/amblyomin-x-having-a-kunitz-type-branco-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/amblyomin-x-having-a-kunitz-type-branco-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/amblyomin-x-having-a-kunitz-type-branco-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/amblyomin-x-having-a-kunitz-type-branco-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/design-synthesis-and-antithrombotic-chen-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/design-synthesis-and-antithrombotic-chen-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/design-synthesis-and-antithrombotic-chen-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/design-synthesis-and-antithrombotic-chen-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/free-flap-salvage-after-tashiro-2016 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/free-flap-salvage-after-tashiro-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/free-flap-salvage-after-tashiro-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/free-flap-salvage-after-tashiro-2016 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/avathrin-a-novel-thrombin-iyer-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/avathrin-a-novel-thrombin-iyer-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/avathrin-a-novel-thrombin-iyer-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/avathrin-a-novel-thrombin-iyer-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/functional-analyses-yield-detailed-pirone-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/functional-analyses-yield-detailed-pirone-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/functional-analyses-yield-detailed-pirone-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/functional-analyses-yield-detailed-pirone-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/is-long-term-post-operative-monitoring-zoccali-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/is-long-term-post-operative-monitoring-zoccali-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/is-long-term-post-operative-monitoring-zoccali-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/is-long-term-post-operative-monitoring-zoccali-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/phylogenetic-analysis-of-placobdella-decarle-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/phylogenetic-analysis-of-placobdella-decarle-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/phylogenetic-analysis-of-placobdella-decarle-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/phylogenetic-analysis-of-placobdella-decarle-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/tyrosine-sulfation-modulates-activity-thompson-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/tyrosine-sulfation-modulates-activity-thompson-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/tyrosine-sulfation-modulates-activity-thompson-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/tyrosine-sulfation-modulates-activity-thompson-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-open-venous-drainage-park-2015 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-open-venous-drainage-park-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-open-venous-drainage-park-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-open-venous-drainage-park-2015 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/patients-experience-of-the-nazir-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/patients-experience-of-the-nazir-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/patients-experience-of-the-nazir-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/patients-experience-of-the-nazir-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-emergency-management-of-adams-1989 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-emergency-management-of-adams-1989 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-emergency-management-of-adams-1989 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-emergency-management-of-adams-1989 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/entrapped-by-the-uneven-darabidarestani-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/entrapped-by-the-uneven-darabidarestani-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/entrapped-by-the-uneven-darabidarestani-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/entrapped-by-the-uneven-darabidarestani-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-evaluation-of-pharmacodynamics-zavyalova-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-evaluation-of-pharmacodynamics-zavyalova-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-evaluation-of-pharmacodynamics-zavyalova-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-evaluation-of-pharmacodynamics-zavyalova-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/improvement-of-the-salvage-rate-matsumine-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/improvement-of-the-salvage-rate-matsumine-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/improvement-of-the-salvage-rate-matsumine-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/improvement-of-the-salvage-rate-matsumine-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/influence-of-venous-stasis-mxfccke-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/influence-of-venous-stasis-mxfccke-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/influence-of-venous-stasis-mxfccke-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/influence-of-venous-stasis-mxfccke-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/functional-cyclophilin-d-moderates-varjxfa-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/functional-cyclophilin-d-moderates-varjxfa-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/functional-cyclophilin-d-moderates-varjxfa-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/functional-cyclophilin-d-moderates-varjxfa-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/novel-diffuse-optics-system-lee-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/novel-diffuse-optics-system-lee-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/novel-diffuse-optics-system-lee-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/novel-diffuse-optics-system-lee-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/outcomes-in-microvascular-head-park-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/outcomes-in-microvascular-head-park-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/outcomes-in-microvascular-head-park-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/outcomes-in-microvascular-head-park-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/using-metabarcoding-to-compare-drinkwater-2018 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/using-metabarcoding-to-compare-drinkwater-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/using-metabarcoding-to-compare-drinkwater-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/using-metabarcoding-to-compare-drinkwater-2018 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-unique-case-of-bharathi-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-unique-case-of-bharathi-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-unique-case-of-bharathi-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-unique-case-of-bharathi-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cardiovascular-considerations-in-anesthetic-shibuya-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cardiovascular-considerations-in-anesthetic-shibuya-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cardiovascular-considerations-in-anesthetic-shibuya-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cardiovascular-considerations-in-anesthetic-shibuya-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/national-population-study-of-hsu-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/national-population-study-of-hsu-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/national-population-study-of-hsu-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/national-population-study-of-hsu-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/unravelling-the-extent-of-arias-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/unravelling-the-extent-of-arias-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/unravelling-the-extent-of-arias-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/unravelling-the-extent-of-arias-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/emergency-amputation-necessitated-within-zhu-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/emergency-amputation-necessitated-within-zhu-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/emergency-amputation-necessitated-within-zhu-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/emergency-amputation-necessitated-within-zhu-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/three-year-2017-2019-activity-report-x17byluk-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/three-year-2017-2019-activity-report-x17byluk-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/three-year-2017-2019-activity-report-x17byluk-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/three-year-2017-2019-activity-report-x17byluk-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/potent-cyclic-peptide-inhibitors-ford-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/potent-cyclic-peptide-inhibitors-ford-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/potent-cyclic-peptide-inhibitors-ford-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/potent-cyclic-peptide-inhibitors-ford-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/artery-only-fingertip-replantation-distal-kaneshiro-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/artery-only-fingertip-replantation-distal-kaneshiro-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/artery-only-fingertip-replantation-distal-kaneshiro-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/artery-only-fingertip-replantation-distal-kaneshiro-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/use-of-an-argatroban-shtoyko-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/use-of-an-argatroban-shtoyko-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/use-of-an-argatroban-shtoyko-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/use-of-an-argatroban-shtoyko-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/detection-of-antibodies-against-kvapil-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/detection-of-antibodies-against-kvapil-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/detection-of-antibodies-against-kvapil-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/detection-of-antibodies-against-kvapil-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/not-just-simple-cellulitis-snels-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/not-just-simple-cellulitis-snels-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/not-just-simple-cellulitis-snels-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/not-just-simple-cellulitis-snels-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparing-the-time-dependent-evolution-moellhoff-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparing-the-time-dependent-evolution-moellhoff-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparing-the-time-dependent-evolution-moellhoff-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparing-the-time-dependent-evolution-moellhoff-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/necrotizing-fasciitis-and-gas-mohanty-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/necrotizing-fasciitis-and-gas-mohanty-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/necrotizing-fasciitis-and-gas-mohanty-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/necrotizing-fasciitis-and-gas-mohanty-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/using-a-chatbot-to-ali-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/using-a-chatbot-to-ali-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/using-a-chatbot-to-ali-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/using-a-chatbot-to-ali-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-interaction-between-anti-pf4-singh-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-interaction-between-anti-pf4-singh-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-interaction-between-anti-pf4-singh-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-interaction-between-anti-pf4-singh-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/thromboprophylaxis-with-argatroban-in-bachler-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/thromboprophylaxis-with-argatroban-in-bachler-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/thromboprophylaxis-with-argatroban-in-bachler-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/thromboprophylaxis-with-argatroban-in-bachler-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/and-human-health-disorders-pessoa-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/and-human-health-disorders-pessoa-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/and-human-health-disorders-pessoa-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/and-human-health-disorders-pessoa-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/immune-response-of-the-fernxe1ndezbravo-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/immune-response-of-the-fernxe1ndezbravo-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/immune-response-of-the-fernxe1ndezbravo-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/immune-response-of-the-fernxe1ndezbravo-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-recombinant-disintegrin-jarastatin-succar-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-recombinant-disintegrin-jarastatin-succar-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-recombinant-disintegrin-jarastatin-succar-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-recombinant-disintegrin-jarastatin-succar-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/outcomes-of-single-digit-wong-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/outcomes-of-single-digit-wong-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/outcomes-of-single-digit-wong-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/outcomes-of-single-digit-wong-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/meningitis-due-to-carbapenemase-producing-vanzo-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/meningitis-due-to-carbapenemase-producing-vanzo-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/meningitis-due-to-carbapenemase-producing-vanzo-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/meningitis-due-to-carbapenemase-producing-vanzo-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/establishment-and-characterization-of-sathiyanarayanan-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/establishment-and-characterization-of-sathiyanarayanan-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/establishment-and-characterization-of-sathiyanarayanan-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/establishment-and-characterization-of-sathiyanarayanan-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/characterization-of-fibroblast-growth-zhang-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/characterization-of-fibroblast-growth-zhang-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/characterization-of-fibroblast-growth-zhang-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/characterization-of-fibroblast-growth-zhang-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/extracorporeal-pedicles-for-free-gimenez-2022 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/extracorporeal-pedicles-for-free-gimenez-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/extracorporeal-pedicles-for-free-gimenez-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/extracorporeal-pedicles-for-free-gimenez-2022 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-management-during-extracorporeal-burx161a-20 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-management-during-extracorporeal-burx161a-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-management-during-extracorporeal-burx161a-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-management-during-extracorporeal-burx161a-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/epidemiological-study-of-ticks-kondo-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/epidemiological-study-of-ticks-kondo-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/epidemiological-study-of-ticks-kondo-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/epidemiological-study-of-ticks-kondo-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/host-defence-peptide-leap2-chen-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/host-defence-peptide-leap2-chen-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/host-defence-peptide-leap2-chen-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/host-defence-peptide-leap2-chen-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/epidemiology-of-secondary-infection-soarescoriolanocoutinho 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/epidemiology-of-secondary-infection-soarescoriolanocoutinho 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/epidemiology-of-secondary-infection-soarescoriolanocoutinho 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/epidemiology-of-secondary-infection-soarescoriolanocoutinho 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/rjararacin-a-recombinant-disintegrin-david-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/rjararacin-a-recombinant-disintegrin-david-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/rjararacin-a-recombinant-disintegrin-david-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/rjararacin-a-recombinant-disintegrin-david-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/high-mortality-risk-of-cheng-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/high-mortality-risk-of-cheng-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/high-mortality-risk-of-cheng-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/high-mortality-risk-of-cheng-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/novel-monitoring-and-dose-ryan-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/novel-monitoring-and-dose-ryan-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/novel-monitoring-and-dose-ryan-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/novel-monitoring-and-dose-ryan-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/whole-spectrum-of-aeromonas-abdella-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/whole-spectrum-of-aeromonas-abdella-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/whole-spectrum-of-aeromonas-abdella-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/whole-spectrum-of-aeromonas-abdella-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-utility-of-smartphone-based-hudson-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-utility-of-smartphone-based-hudson-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-utility-of-smartphone-based-hudson-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-utility-of-smartphone-based-hudson-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/post-traumatic-aeromonas-hydrophila-osteomyelitis-tsunoda-20 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/post-traumatic-aeromonas-hydrophila-osteomyelitis-tsunoda-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/post-traumatic-aeromonas-hydrophila-osteomyelitis-tsunoda-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/post-traumatic-aeromonas-hydrophila-osteomyelitis-tsunoda-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/thymosin-beta-4-participate-in-lin-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/thymosin-beta-4-participate-in-lin-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/thymosin-beta-4-participate-in-lin-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/thymosin-beta-4-participate-in-lin-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/evolution-of-an-alternative-manzanomarxedn-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/evolution-of-an-alternative-manzanomarxedn-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/evolution-of-an-alternative-manzanomarxedn-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/evolution-of-an-alternative-manzanomarxedn-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/aptamer-thrombin-loaded-magnetic-microspheres-cao-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/aptamer-thrombin-loaded-magnetic-microspheres-cao-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/aptamer-thrombin-loaded-magnetic-microspheres-cao-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/aptamer-thrombin-loaded-magnetic-microspheres-cao-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/monitoring-of-argatroban-in-heubner-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/monitoring-of-argatroban-in-heubner-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/monitoring-of-argatroban-in-heubner-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/monitoring-of-argatroban-in-heubner-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/role-of-infrared-thermography-chava-2023 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/role-of-infrared-thermography-chava-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/role-of-infrared-thermography-chava-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/role-of-infrared-thermography-chava-2023 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/partial-hand-replantation-using-celestin-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/partial-hand-replantation-using-celestin-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/partial-hand-replantation-using-celestin-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/partial-hand-replantation-using-celestin-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/discovery-of-a-novel-sosajimxe9nez-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/discovery-of-a-novel-sosajimxe9nez-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/discovery-of-a-novel-sosajimxe9nez-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/discovery-of-a-novel-sosajimxe9nez-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-rare-case-of-bulsara-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-rare-case-of-bulsara-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-rare-case-of-bulsara-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-rare-case-of-bulsara-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/isolation-characterization-and-immunomodulatory-dias-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/isolation-characterization-and-immunomodulatory-dias-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/isolation-characterization-and-immunomodulatory-dias-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/isolation-characterization-and-immunomodulatory-dias-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/percutaneous-transluminal-angioplasty-alleviate-tan-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/percutaneous-transluminal-angioplasty-alleviate-tan-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/percutaneous-transluminal-angioplasty-alleviate-tan-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/percutaneous-transluminal-angioplasty-alleviate-tan-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/structural-biochemical-characterization-and-saghour-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/structural-biochemical-characterization-and-saghour-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/structural-biochemical-characterization-and-saghour-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/structural-biochemical-characterization-and-saghour-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/current-trends-in-digital-chang-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/current-trends-in-digital-chang-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/current-trends-in-digital-chang-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/current-trends-in-digital-chang-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-microvascular-anastomotic-coupler-farsi-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-microvascular-anastomotic-coupler-farsi-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-microvascular-anastomotic-coupler-farsi-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-microvascular-anastomotic-coupler-farsi-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/predicting-the-timing-and-gupta-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/predicting-the-timing-and-gupta-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/predicting-the-timing-and-gupta-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/predicting-the-timing-and-gupta-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/health-policy-implications-of-lim-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/health-policy-implications-of-lim-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/health-policy-implications-of-lim-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/health-policy-implications-of-lim-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-learning-curve-in-hustedt-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-learning-curve-in-hustedt-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-learning-curve-in-hustedt-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-learning-curve-in-hustedt-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/engineering-hirudin-encapsulation-in-mei-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/engineering-hirudin-encapsulation-in-mei-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/engineering-hirudin-encapsulation-in-mei-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/engineering-hirudin-encapsulation-in-mei-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/evaluation-of-per-and-calisi-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/evaluation-of-per-and-calisi-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/evaluation-of-per-and-calisi-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/evaluation-of-per-and-calisi-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/resolution-of-vascular-compromise-rivkin-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/resolution-of-vascular-compromise-rivkin-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/resolution-of-vascular-compromise-rivkin-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/resolution-of-vascular-compromise-rivkin-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/targeted-genome-mining-facilitates-hoffman-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/targeted-genome-mining-facilitates-hoffman-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/targeted-genome-mining-facilitates-hoffman-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/targeted-genome-mining-facilitates-hoffman-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/identification-of-a-novel-chen-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/identification-of-a-novel-chen-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/identification-of-a-novel-chen-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/identification-of-a-novel-chen-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/identification-screening-and-comprehensive-chai-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/identification-screening-and-comprehensive-chai-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/identification-screening-and-comprehensive-chai-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/identification-screening-and-comprehensive-chai-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulant-associated-calciphylaxis-analysis-of-sridharan 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulant-associated-calciphylaxis-analysis-of-sridharan 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulant-associated-calciphylaxis-analysis-of-sridharan 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulant-associated-calciphylaxis-analysis-of-sridharan 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/fulminant-edwardsiella-tarda-bacteremia-fujita-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/fulminant-edwardsiella-tarda-bacteremia-fujita-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/fulminant-edwardsiella-tarda-bacteremia-fujita-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/fulminant-edwardsiella-tarda-bacteremia-fujita-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/emergingspp-infections-in-europe-schwartz-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/emergingspp-infections-in-europe-schwartz-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/emergingspp-infections-in-europe-schwartz-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/emergingspp-infections-in-europe-schwartz-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/fadd-cooperates-with-caspase-8-wang-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/fadd-cooperates-with-caspase-8-wang-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/fadd-cooperates-with-caspase-8-wang-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/fadd-cooperates-with-caspase-8-wang-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cangrelor-use-for-viabahn-cheng-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cangrelor-use-for-viabahn-cheng-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cangrelor-use-for-viabahn-cheng-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cangrelor-use-for-viabahn-cheng-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/fishhook-injuries-and-antibiotic-lazzara-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/fishhook-injuries-and-antibiotic-lazzara-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/fishhook-injuries-and-antibiotic-lazzara-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/fishhook-injuries-and-antibiotic-lazzara-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/assessment-of-simulation-training-he-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/assessment-of-simulation-training-he-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/assessment-of-simulation-training-he-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/assessment-of-simulation-training-he-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/complement-function-and-activation-andersson-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/complement-function-and-activation-andersson-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/complement-function-and-activation-andersson-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/complement-function-and-activation-andersson-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-like-noninvasive-polyurethane-solid-qu-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-like-noninvasive-polyurethane-solid-qu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-like-noninvasive-polyurethane-solid-qu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-like-noninvasive-polyurethane-solid-qu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/retraction-hirudin-ameliorates-immunoglobulin-na-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/retraction-hirudin-ameliorates-immunoglobulin-na-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/retraction-hirudin-ameliorates-immunoglobulin-na-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/retraction-hirudin-ameliorates-immunoglobulin-na-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/enhanced-hemocompatibility-via-bivalirudin-ammann-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/enhanced-hemocompatibility-via-bivalirudin-ammann-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/enhanced-hemocompatibility-via-bivalirudin-ammann-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/enhanced-hemocompatibility-via-bivalirudin-ammann-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/critical-review-of-international-rosson-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/critical-review-of-international-rosson-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/critical-review-of-international-rosson-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/critical-review-of-international-rosson-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/secondary-infection-with-aeromonas-villa-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/secondary-infection-with-aeromonas-villa-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/secondary-infection-with-aeromonas-villa-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/secondary-infection-with-aeromonas-villa-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/interventional-radiological-management-for-xia-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/interventional-radiological-management-for-xia-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/interventional-radiological-management-for-xia-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/interventional-radiological-management-for-xia-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-ethnoveterinary-study-of-teshome-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-ethnoveterinary-study-of-teshome-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-ethnoveterinary-study-of-teshome-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-ethnoveterinary-study-of-teshome-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/early-detection-and-successful-ida-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/early-detection-and-successful-ida-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/early-detection-and-successful-ida-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/early-detection-and-successful-ida-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/analgesic-effect-of-medicinal-aminov-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/analgesic-effect-of-medicinal-aminov-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/analgesic-effect-of-medicinal-aminov-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/analgesic-effect-of-medicinal-aminov-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/apixaban-eliquis-for-venous-bricker-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/apixaban-eliquis-for-venous-bricker-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/apixaban-eliquis-for-venous-bricker-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/apixaban-eliquis-for-venous-bricker-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/isolation-of-largemouth-bass-leng-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/isolation-of-largemouth-bass-leng-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/isolation-of-largemouth-bass-leng-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/isolation-of-largemouth-bass-leng-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/hirudin-alleviates-renal-fibrosis-long-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/hirudin-alleviates-renal-fibrosis-long-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/hirudin-alleviates-renal-fibrosis-long-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/hirudin-alleviates-renal-fibrosis-long-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/optimizing-fingertip-reconstruction-a-miyashima-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/optimizing-fingertip-reconstruction-a-miyashima-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/optimizing-fingertip-reconstruction-a-miyashima-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/optimizing-fingertip-reconstruction-a-miyashima-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/global-spread-and-antimicrobial-jeamsripong-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/global-spread-and-antimicrobial-jeamsripong-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/global-spread-and-antimicrobial-jeamsripong-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/global-spread-and-antimicrobial-jeamsripong-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/feed-status-and-skin-soku-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/feed-status-and-skin-soku-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/feed-status-and-skin-soku-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/feed-status-and-skin-soku-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cytotoxicity-and-antiplatelet-activity-moroz-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cytotoxicity-and-antiplatelet-activity-moroz-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cytotoxicity-and-antiplatelet-activity-moroz-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cytotoxicity-and-antiplatelet-activity-moroz-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/aeromonas-hydrophila-related-fulminant-necrotizing-zhang-202 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/aeromonas-hydrophila-related-fulminant-necrotizing-zhang-202 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/aeromonas-hydrophila-related-fulminant-necrotizing-zhang-202 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/aeromonas-hydrophila-related-fulminant-necrotizing-zhang-202 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/deep-inferior-epigastric-perforator-haiatfactor-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/deep-inferior-epigastric-perforator-haiatfactor-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/deep-inferior-epigastric-perforator-haiatfactor-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/deep-inferior-epigastric-perforator-haiatfactor-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/reduced-dose-versus-full-dose-direct-akhtar-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/reduced-dose-versus-full-dose-direct-akhtar-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/reduced-dose-versus-full-dose-direct-akhtar-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/reduced-dose-versus-full-dose-direct-akhtar-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/impairment-of-collagen-induced-thrombus-melnikova-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/impairment-of-collagen-induced-thrombus-melnikova-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/impairment-of-collagen-induced-thrombus-melnikova-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/impairment-of-collagen-induced-thrombus-melnikova-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/editorial-refining-the-hemocompatibility-molina-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/editorial-refining-the-hemocompatibility-molina-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/editorial-refining-the-hemocompatibility-molina-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/editorial-refining-the-hemocompatibility-molina-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/incidence-risk-factors-and-wu-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/incidence-risk-factors-and-wu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/incidence-risk-factors-and-wu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/incidence-risk-factors-and-wu-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/evolution-of-neutrophil-extracellular-ning-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/evolution-of-neutrophil-extracellular-ning-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/evolution-of-neutrophil-extracellular-ning-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/evolution-of-neutrophil-extracellular-ning-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/infrared-thermography-for-early-mayakuntla-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/infrared-thermography-for-early-mayakuntla-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/infrared-thermography-for-early-mayakuntla-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/infrared-thermography-for-early-mayakuntla-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparative-study-of-hirudins-yin-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparative-study-of-hirudins-yin-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparative-study-of-hirudins-yin-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparative-study-of-hirudins-yin-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/type-ii-heparin-induced-thrombocytopenia-zhang-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/type-ii-heparin-induced-thrombocytopenia-zhang-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/type-ii-heparin-induced-thrombocytopenia-zhang-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/type-ii-heparin-induced-thrombocytopenia-zhang-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/plasma-exchange-in-the-labarinas-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/plasma-exchange-in-the-labarinas-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/plasma-exchange-in-the-labarinas-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/plasma-exchange-in-the-labarinas-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/complications-of-cerebral-venous-lozouet-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/complications-of-cerebral-venous-lozouet-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/complications-of-cerebral-venous-lozouet-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/complications-of-cerebral-venous-lozouet-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/does-academic-quarter-or-sobba-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/does-academic-quarter-or-sobba-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/does-academic-quarter-or-sobba-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/does-academic-quarter-or-sobba-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/experience-with-invasiveinfections-at-henrichs-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/experience-with-invasiveinfections-at-henrichs-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/experience-with-invasiveinfections-at-henrichs-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/experience-with-invasiveinfections-at-henrichs-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/avoiding-the-vicious-cycle-brijlal-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/avoiding-the-vicious-cycle-brijlal-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/avoiding-the-vicious-cycle-brijlal-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/avoiding-the-vicious-cycle-brijlal-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prophylaxis-of-venous-thromboembolism-lippincott-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prophylaxis-of-venous-thromboembolism-lippincott-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prophylaxis-of-venous-thromboembolism-lippincott-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prophylaxis-of-venous-thromboembolism-lippincott-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/immersive-virtual-reality-for-prahm-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/immersive-virtual-reality-for-prahm-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/immersive-virtual-reality-for-prahm-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/immersive-virtual-reality-for-prahm-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/measuring-direct-oral-anticoagulant-sorrentino-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/measuring-direct-oral-anticoagulant-sorrentino-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/measuring-direct-oral-anticoagulant-sorrentino-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/measuring-direct-oral-anticoagulant-sorrentino-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/quality-of-safety-reports-matveev-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/quality-of-safety-reports-matveev-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/quality-of-safety-reports-matveev-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/quality-of-safety-reports-matveev-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/effect-of-concurrent-use-kho-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/effect-of-concurrent-use-kho-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/effect-of-concurrent-use-kho-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/effect-of-concurrent-use-kho-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/apixaban-vs-vitamin-k-aarts-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/apixaban-vs-vitamin-k-aarts-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/apixaban-vs-vitamin-k-aarts-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/apixaban-vs-vitamin-k-aarts-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/proposal-for-a-tooth-higashi-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/proposal-for-a-tooth-higashi-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/proposal-for-a-tooth-higashi-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/proposal-for-a-tooth-higashi-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/abnormal-uterine-bleeding-among-yellin-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/abnormal-uterine-bleeding-among-yellin-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/abnormal-uterine-bleeding-among-yellin-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/abnormal-uterine-bleeding-among-yellin-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/design-and-rationale-of-ahn-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/design-and-rationale-of-ahn-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/design-and-rationale-of-ahn-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/design-and-rationale-of-ahn-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/laminin-g-domains-define-yasmin-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/laminin-g-domains-define-yasmin-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/laminin-g-domains-define-yasmin-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/laminin-g-domains-define-yasmin-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-thrombocytopenia-causing-early-abdelaziz-202 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-thrombocytopenia-causing-early-abdelaziz-202 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-thrombocytopenia-causing-early-abdelaziz-202 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-thrombocytopenia-causing-early-abdelaziz-202 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-prophylaxis-in-purcell-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-prophylaxis-in-purcell-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-prophylaxis-in-purcell-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-prophylaxis-in-purcell-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/naringin-binds-and-activates-siddiqui-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/naringin-binds-and-activates-siddiqui-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/naringin-binds-and-activates-siddiqui-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/naringin-binds-and-activates-siddiqui-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/recent-progress-on-formulations-bao-2025 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/recent-progress-on-formulations-bao-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/recent-progress-on-formulations-bao-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/recent-progress-on-formulations-bao-2025 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/targeting-factor-xi-for-campanella-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/targeting-factor-xi-for-campanella-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/targeting-factor-xi-for-campanella-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/targeting-factor-xi-for-campanella-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficacy-and-safety-of-aperna-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficacy-and-safety-of-aperna-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficacy-and-safety-of-aperna-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficacy-and-safety-of-aperna-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cutting-through-the-clot-zhou-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cutting-through-the-clot-zhou-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cutting-through-the-clot-zhou-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cutting-through-the-clot-zhou-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-oral-anticoagulants-for-zhu-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-oral-anticoagulants-for-zhu-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-oral-anticoagulants-for-zhu-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-oral-anticoagulants-for-zhu-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/perioperative-management-of-immune-said-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/perioperative-management-of-immune-said-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/perioperative-management-of-immune-said-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/perioperative-management-of-immune-said-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/economic-evaluation-of-direct-karimi-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/economic-evaluation-of-direct-karimi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/economic-evaluation-of-direct-karimi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/economic-evaluation-of-direct-karimi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/antithrombotic-therapy-for-cancer-associated-dileo-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/antithrombotic-therapy-for-cancer-associated-dileo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/antithrombotic-therapy-for-cancer-associated-dileo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/antithrombotic-therapy-for-cancer-associated-dileo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-multicenter-prospective-real-world-meena-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-multicenter-prospective-real-world-meena-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-multicenter-prospective-real-world-meena-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-multicenter-prospective-real-world-meena-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/sibakazin-a-novel-black-li-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/sibakazin-a-novel-black-li-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/sibakazin-a-novel-black-li-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/sibakazin-a-novel-black-li-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-risk-for-bleeding-dawwas-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-risk-for-bleeding-dawwas-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-risk-for-bleeding-dawwas-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-risk-for-bleeding-dawwas-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/scoping-review-of-apixaban-gillis-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/scoping-review-of-apixaban-gillis-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/scoping-review-of-apixaban-gillis-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/scoping-review-of-apixaban-gillis-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/unmet-needs-and-challenges-nusrat-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/unmet-needs-and-challenges-nusrat-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/unmet-needs-and-challenges-nusrat-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/unmet-needs-and-challenges-nusrat-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-advances-in-novel-li-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-advances-in-novel-li-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-advances-in-novel-li-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-advances-in-novel-li-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/arterial-only-anastomosis-for-fingertip-weng-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/arterial-only-anastomosis-for-fingertip-weng-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/arterial-only-anastomosis-for-fingertip-weng-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/arterial-only-anastomosis-for-fingertip-weng-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-impact-of-anticoagulation-borad-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-impact-of-anticoagulation-borad-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-impact-of-anticoagulation-borad-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-impact-of-anticoagulation-borad-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/from-physiology-to-clinical-jarowicz-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/from-physiology-to-clinical-jarowicz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/from-physiology-to-clinical-jarowicz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/from-physiology-to-clinical-jarowicz-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-association-of-extended-fong-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-association-of-extended-fong-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-association-of-extended-fong-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-association-of-extended-fong-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/interference-in-protein-s-yan-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/interference-in-protein-s-yan-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/interference-in-protein-s-yan-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/interference-in-protein-s-yan-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/use-of-apixaban-for-alanizi-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/use-of-apixaban-for-alanizi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/use-of-apixaban-for-alanizi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/use-of-apixaban-for-alanizi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/does-indocyanine-green-fluorescence-laget-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/does-indocyanine-green-fluorescence-laget-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/does-indocyanine-green-fluorescence-laget-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/does-indocyanine-green-fluorescence-laget-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/protein-exosites-as-drug-omage-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/protein-exosites-as-drug-omage-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/protein-exosites-as-drug-omage-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/protein-exosites-as-drug-omage-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/transcriptomic-classification-and-clinicopathologic-zhu-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/transcriptomic-classification-and-clinicopathologic-zhu-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/transcriptomic-classification-and-clinicopathologic-zhu-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/transcriptomic-classification-and-clinicopathologic-zhu-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/large-bore-mechanical-thrombectomy-with-lin-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/large-bore-mechanical-thrombectomy-with-lin-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/large-bore-mechanical-thrombectomy-with-lin-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/large-bore-mechanical-thrombectomy-with-lin-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/safety-and-efficacy-of-chen-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/safety-and-efficacy-of-chen-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/safety-and-efficacy-of-chen-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/safety-and-efficacy-of-chen-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/single-center-retrospective-comparison-habiger-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/single-center-retrospective-comparison-habiger-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/single-center-retrospective-comparison-habiger-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/single-center-retrospective-comparison-habiger-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-graft-reposition-on-flap-technique-for-thushara-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-graft-reposition-on-flap-technique-for-thushara-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-graft-reposition-on-flap-technique-for-thushara-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-graft-reposition-on-flap-technique-for-thushara-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-in-pulmonary-embolism-ursoleo-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-in-pulmonary-embolism-ursoleo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-in-pulmonary-embolism-ursoleo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-in-pulmonary-embolism-ursoleo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/clinical-outcomes-of-direct-zhang-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/clinical-outcomes-of-direct-zhang-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/clinical-outcomes-of-direct-zhang-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/clinical-outcomes-of-direct-zhang-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-in-pelvic-vogel-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-in-pelvic-vogel-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-in-pelvic-vogel-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-in-pelvic-vogel-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/thrombosis-across-female-specific-malignancies-aghakouchakza 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/thrombosis-across-female-specific-malignancies-aghakouchakza 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/thrombosis-across-female-specific-malignancies-aghakouchakza 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/thrombosis-across-female-specific-malignancies-aghakouchakza 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/mechanistic-prediction-of-apixaban-yi-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/mechanistic-prediction-of-apixaban-yi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/mechanistic-prediction-of-apixaban-yi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/mechanistic-prediction-of-apixaban-yi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/measurement-of-active-thrombin-stikarova-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/measurement-of-active-thrombin-stikarova-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/measurement-of-active-thrombin-stikarova-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/measurement-of-active-thrombin-stikarova-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/role-of-concentration-in-burrell-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/role-of-concentration-in-burrell-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/role-of-concentration-in-burrell-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/role-of-concentration-in-burrell-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/single-domain-antibodies-to-reverse-zhao-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/single-domain-antibodies-to-reverse-zhao-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/single-domain-antibodies-to-reverse-zhao-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/single-domain-antibodies-to-reverse-zhao-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/continuous-vs-interrupted-direct-xiang-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/continuous-vs-interrupted-direct-xiang-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/continuous-vs-interrupted-direct-xiang-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/continuous-vs-interrupted-direct-xiang-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/stroke-and-bleeding-risks-bradley-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/stroke-and-bleeding-risks-bradley-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/stroke-and-bleeding-risks-bradley-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/stroke-and-bleeding-risks-bradley-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/case-report-post-traumaticinfection-causing-shang-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/case-report-post-traumaticinfection-causing-shang-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/case-report-post-traumaticinfection-causing-shang-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/case-report-post-traumaticinfection-causing-shang-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/direct-oral-anticoagulants-versus-metwaly-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/direct-oral-anticoagulants-versus-metwaly-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/direct-oral-anticoagulants-versus-metwaly-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/direct-oral-anticoagulants-versus-metwaly-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparative-safety-of-direct-brodin-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparative-safety-of-direct-brodin-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparative-safety-of-direct-brodin-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparative-safety-of-direct-brodin-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-of-suspected-heparin-tam-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-of-suspected-heparin-tam-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-of-suspected-heparin-tam-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-of-suspected-heparin-tam-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/post-assault-brachial-vein-thrombosis-sumawe-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/post-assault-brachial-vein-thrombosis-sumawe-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/post-assault-brachial-vein-thrombosis-sumawe-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/post-assault-brachial-vein-thrombosis-sumawe-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prescribing-patterns-and-clinician-riva-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prescribing-patterns-and-clinician-riva-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prescribing-patterns-and-clinician-riva-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prescribing-patterns-and-clinician-riva-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-structure-of-thrombin-bode-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-structure-of-thrombin-bode-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-structure-of-thrombin-bode-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-structure-of-thrombin-bode-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/design-synthesis-and-biological-lin-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/design-synthesis-and-biological-lin-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/design-synthesis-and-biological-lin-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/design-synthesis-and-biological-lin-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-cofactor-ii-modulates-tollefsen-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-cofactor-ii-modulates-tollefsen-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-cofactor-ii-modulates-tollefsen-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-cofactor-ii-modulates-tollefsen-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/clot-structure-modification-by-varin-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/clot-structure-modification-by-varin-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/clot-structure-modification-by-varin-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/clot-structure-modification-by-varin-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/old-and-new-natural-beretz-1991 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/old-and-new-natural-beretz-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/old-and-new-natural-beretz-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/old-and-new-natural-beretz-1991 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/free-flap-reexploration-indications-bui-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/free-flap-reexploration-indications-bui-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/free-flap-reexploration-indications-bui-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/free-flap-reexploration-indications-bui-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/early-reintervention-of-compromised-smit-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/early-reintervention-of-compromised-smit-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/early-reintervention-of-compromised-smit-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/early-reintervention-of-compromised-smit-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-picture-speaks-a-varkey-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-picture-speaks-a-varkey-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-picture-speaks-a-varkey-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-picture-speaks-a-varkey-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/platelet-gpib-complex-as-clemetson-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/platelet-gpib-complex-as-clemetson-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/platelet-gpib-complex-as-clemetson-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/platelet-gpib-complex-as-clemetson-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/peptides-and-pseudopeptides-incorporating-ilas-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/peptides-and-pseudopeptides-incorporating-ilas-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/peptides-and-pseudopeptides-incorporating-ilas-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/peptides-and-pseudopeptides-incorporating-ilas-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/external-monitor-for-buried-pellini-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/external-monitor-for-buried-pellini-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/external-monitor-for-buried-pellini-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/external-monitor-for-buried-pellini-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/postoperative-monitoring-of-microsurgical-abdelgalil-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/postoperative-monitoring-of-microsurgical-abdelgalil-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/postoperative-monitoring-of-microsurgical-abdelgalil-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/postoperative-monitoring-of-microsurgical-abdelgalil-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/postoperative-monitoring-of-microsurgical-abdelgalil-2009-2 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/postoperative-monitoring-of-microsurgical-abdelgalil-2009-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/postoperative-monitoring-of-microsurgical-abdelgalil-2009-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/postoperative-monitoring-of-microsurgical-abdelgalil-2009-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/aeruginosin-analogs-and-other-wang-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/aeruginosin-analogs-and-other-wang-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/aeruginosin-analogs-and-other-wang-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/aeruginosin-analogs-and-other-wang-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/free-flap-failures-and-complications-salama-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/free-flap-failures-and-complications-salama-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/free-flap-failures-and-complications-salama-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/free-flap-failures-and-complications-salama-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/old-and-new-natural-beretz-1991-2 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/old-and-new-natural-beretz-1991-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/old-and-new-natural-beretz-1991-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/old-and-new-natural-beretz-1991-2 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/from-heparin-to-ep217609-petitou-2009 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/from-heparin-to-ep217609-petitou-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/from-heparin-to-ep217609-petitou-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/from-heparin-to-ep217609-petitou-2009 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/structure-based-design-of-residue-girnys-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/structure-based-design-of-residue-girnys-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/structure-based-design-of-residue-girnys-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/structure-based-design-of-residue-girnys-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/postoperative-monitoring-of-lower-rozen-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/postoperative-monitoring-of-lower-rozen-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/postoperative-monitoring-of-lower-rozen-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/postoperative-monitoring-of-lower-rozen-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/unique-extracellular-matrix-heparan-gomes-2010 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/unique-extracellular-matrix-heparan-gomes-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/unique-extracellular-matrix-heparan-gomes-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/unique-extracellular-matrix-heparan-gomes-2010 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/review-of-100-consecutive-gao-2011 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/review-of-100-consecutive-gao-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/review-of-100-consecutive-gao-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/review-of-100-consecutive-gao-2011 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/quality-improvement-of-microsurgery-chen-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/quality-improvement-of-microsurgery-chen-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/quality-improvement-of-microsurgery-chen-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/quality-improvement-of-microsurgery-chen-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/discovery-of-1-3-diaminobenzenes-as-dockendorff-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/discovery-of-1-3-diaminobenzenes-as-dockendorff-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/discovery-of-1-3-diaminobenzenes-as-dockendorff-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/discovery-of-1-3-diaminobenzenes-as-dockendorff-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/novel-use-of-a-fedor-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/novel-use-of-a-fedor-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/novel-use-of-a-fedor-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/novel-use-of-a-fedor-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/rational-design-and-characterization-figueiredo-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/rational-design-and-characterization-figueiredo-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/rational-design-and-characterization-figueiredo-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/rational-design-and-characterization-figueiredo-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/analysis-of-an-implantable-zhang-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/analysis-of-an-implantable-zhang-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/analysis-of-an-implantable-zhang-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/analysis-of-an-implantable-zhang-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/exploration-of-the-antiplatelet-tzakos-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/exploration-of-the-antiplatelet-tzakos-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/exploration-of-the-antiplatelet-tzakos-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/exploration-of-the-antiplatelet-tzakos-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/monitoring-in-microvascular-tissue-jonas-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/monitoring-in-microvascular-tissue-jonas-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/monitoring-in-microvascular-tissue-jonas-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/monitoring-in-microvascular-tissue-jonas-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/unique-thrombin-inhibition-mechanism-figueiredo-2012 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/unique-thrombin-inhibition-mechanism-figueiredo-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/unique-thrombin-inhibition-mechanism-figueiredo-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/unique-thrombin-inhibition-mechanism-figueiredo-2012 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-eyes-have-it-siddall-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-eyes-have-it-siddall-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-eyes-have-it-siddall-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-eyes-have-it-siddall-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/evolution-of-clitellate-phaosomes-dxf6ring-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/evolution-of-clitellate-phaosomes-dxf6ring-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/evolution-of-clitellate-phaosomes-dxf6ring-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/evolution-of-clitellate-phaosomes-dxf6ring-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/an-update-on-recent-mehta-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/an-update-on-recent-mehta-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/an-update-on-recent-mehta-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/an-update-on-recent-mehta-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/differential-expression-of-conserved-cho-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/differential-expression-of-conserved-cho-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/differential-expression-of-conserved-cho-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/differential-expression-of-conserved-cho-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/antithrombotic-activities-of-epi-sesamin-ku-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/antithrombotic-activities-of-epi-sesamin-ku-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/antithrombotic-activities-of-epi-sesamin-ku-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/antithrombotic-activities-of-epi-sesamin-ku-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/flow-through-flap-for-salvage-parr-2013 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/flow-through-flap-for-salvage-parr-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/flow-through-flap-for-salvage-parr-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/flow-through-flap-for-salvage-parr-2013 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/improved-technique-for-evaluating-nagata-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/improved-technique-for-evaluating-nagata-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/improved-technique-for-evaluating-nagata-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/improved-technique-for-evaluating-nagata-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/early-experiences-with-microvascular-mofikoya-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/early-experiences-with-microvascular-mofikoya-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/early-experiences-with-microvascular-mofikoya-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/early-experiences-with-microvascular-mofikoya-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/rationale-for-the-use-ho-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/rationale-for-the-use-ho-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/rationale-for-the-use-ho-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/rationale-for-the-use-ho-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/diep-flap-sentinel-skin-laporta-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/diep-flap-sentinel-skin-laporta-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/diep-flap-sentinel-skin-laporta-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/diep-flap-sentinel-skin-laporta-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/antithrombotic-activities-of-sulforaphane-ku-2014 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/antithrombotic-activities-of-sulforaphane-ku-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/antithrombotic-activities-of-sulforaphane-ku-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/antithrombotic-activities-of-sulforaphane-ku-2014 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/noncovalent-tripeptidic-thrombin-inhibitors-lee-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/noncovalent-tripeptidic-thrombin-inhibitors-lee-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/noncovalent-tripeptidic-thrombin-inhibitors-lee-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/noncovalent-tripeptidic-thrombin-inhibitors-lee-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pharmacokinetics-of-new-synthetic-hxe9rault-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pharmacokinetics-of-new-synthetic-hxe9rault-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pharmacokinetics-of-new-synthetic-hxe9rault-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pharmacokinetics-of-new-synthetic-hxe9rault-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/unique-overlap-in-the-adang-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/unique-overlap-in-the-adang-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/unique-overlap-in-the-adang-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/unique-overlap-in-the-adang-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-2-sulfated-3-linked-alpha-l-galactan-pereira-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-2-sulfated-3-linked-alpha-l-galactan-pereira-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-2-sulfated-3-linked-alpha-l-galactan-pereira-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-2-sulfated-3-linked-alpha-l-galactan-pereira-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/g-protein-coupled-receptor-antagonists-1-chackalamannil-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/g-protein-coupled-receptor-antagonists-1-chackalamannil-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/g-protein-coupled-receptor-antagonists-1-chackalamannil-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/g-protein-coupled-receptor-antagonists-1-chackalamannil-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/structure-based-drug-design-of-south-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/structure-based-drug-design-of-south-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/structure-based-drug-design-of-south-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/structure-based-drug-design-of-south-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/efficacious-and-orally-bioavailable-lee-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/efficacious-and-orally-bioavailable-lee-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/efficacious-and-orally-bioavailable-lee-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/efficacious-and-orally-bioavailable-lee-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/antithrombotic-properties-of-a-vogel-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/antithrombotic-properties-of-a-vogel-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/antithrombotic-properties-of-a-vogel-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/antithrombotic-properties-of-a-vogel-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/design-parallel-synthesis-and-parlow-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/design-parallel-synthesis-and-parlow-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/design-parallel-synthesis-and-parlow-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/design-parallel-synthesis-and-parlow-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-synthetic-antithrombin-iii-petitou-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-synthetic-antithrombin-iii-petitou-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-synthetic-antithrombin-iii-petitou-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-synthetic-antithrombin-iii-petitou-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/differential-activation-and-inhibition-soslau-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/differential-activation-and-inhibition-soslau-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/differential-activation-and-inhibition-soslau-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/differential-activation-and-inhibition-soslau-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/discovery-of-potent-peptide-mimetic-maryanoff-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/discovery-of-potent-peptide-mimetic-maryanoff-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/discovery-of-potent-peptide-mimetic-maryanoff-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/discovery-of-potent-peptide-mimetic-maryanoff-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/non-peptidic-small-molecule-antagonists-of-selnick-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/non-peptidic-small-molecule-antagonists-of-selnick-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/non-peptidic-small-molecule-antagonists-of-selnick-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/non-peptidic-small-molecule-antagonists-of-selnick-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/potential-pharmacological-applications-of-chavakis-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/potential-pharmacological-applications-of-chavakis-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/potential-pharmacological-applications-of-chavakis-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/potential-pharmacological-applications-of-chavakis-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-heparin-binding-properties-okeeffe-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-heparin-binding-properties-okeeffe-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-heparin-binding-properties-okeeffe-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-heparin-binding-properties-okeeffe-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/full-or-partial-substitution-filion-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/full-or-partial-substitution-filion-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/full-or-partial-substitution-filion-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/full-or-partial-substitution-filion-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/modulators-of-the-coagulation-frxe9dxe9rick-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/modulators-of-the-coagulation-frxe9dxe9rick-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/modulators-of-the-coagulation-frxe9dxe9rick-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/modulators-of-the-coagulation-frxe9dxe9rick-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/in-depth-study-of-tripeptide-based-costanzo-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/in-depth-study-of-tripeptide-based-costanzo-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/in-depth-study-of-tripeptide-based-costanzo-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/in-depth-study-of-tripeptide-based-costanzo-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/short-and-long-acting-synthetic-walenga-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/short-and-long-acting-synthetic-walenga-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/short-and-long-acting-synthetic-walenga-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/short-and-long-acting-synthetic-walenga-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/leech-bite-a-rare-saha-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/leech-bite-a-rare-saha-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/leech-bite-a-rare-saha-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/leech-bite-a-rare-saha-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/reperfusion-thrombolytic-therapy-for-karaszewski-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/reperfusion-thrombolytic-therapy-for-karaszewski-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/reperfusion-thrombolytic-therapy-for-karaszewski-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/reperfusion-thrombolytic-therapy-for-karaszewski-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/ticagrelor-induced-false-negative-serotonin-release-jamil-20 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/ticagrelor-induced-false-negative-serotonin-release-jamil-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/ticagrelor-induced-false-negative-serotonin-release-jamil-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/ticagrelor-induced-false-negative-serotonin-release-jamil-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pediatric-lemierre-s-syndrome-a-aldawsari-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pediatric-lemierre-s-syndrome-a-aldawsari-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pediatric-lemierre-s-syndrome-a-aldawsari-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pediatric-lemierre-s-syndrome-a-aldawsari-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparative-efficacy-and-safety-wu-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparative-efficacy-and-safety-wu-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparative-efficacy-and-safety-wu-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparative-efficacy-and-safety-wu-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/optimizing-artificial-lung-preservation-wieruszewski-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/optimizing-artificial-lung-preservation-wieruszewski-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/optimizing-artificial-lung-preservation-wieruszewski-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/optimizing-artificial-lung-preservation-wieruszewski-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/association-of-edoxaban-pharmacokinetics-okumura-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/association-of-edoxaban-pharmacokinetics-okumura-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/association-of-edoxaban-pharmacokinetics-okumura-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/association-of-edoxaban-pharmacokinetics-okumura-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/bivalirudin-for-recurrent-pediatric-shelley-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/bivalirudin-for-recurrent-pediatric-shelley-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/bivalirudin-for-recurrent-pediatric-shelley-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/bivalirudin-for-recurrent-pediatric-shelley-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pharmacologic-thromboprophylaxis-in-medical-marti-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pharmacologic-thromboprophylaxis-in-medical-marti-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pharmacologic-thromboprophylaxis-in-medical-marti-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pharmacologic-thromboprophylaxis-in-medical-marti-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/tailored-management-of-a-viterbo-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/tailored-management-of-a-viterbo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/tailored-management-of-a-viterbo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/tailored-management-of-a-viterbo-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/managing-bleeding-risk-in-alexandrino-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/managing-bleeding-risk-in-alexandrino-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/managing-bleeding-risk-in-alexandrino-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/managing-bleeding-risk-in-alexandrino-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/pharmacological-thromboprophylaxis-after-varicose-cabrerofer 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/pharmacological-thromboprophylaxis-after-varicose-cabrerofer 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/pharmacological-thromboprophylaxis-after-varicose-cabrerofer 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/pharmacological-thromboprophylaxis-after-varicose-cabrerofer 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparative-analysis-of-anticoagulation-khan-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparative-analysis-of-anticoagulation-khan-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparative-analysis-of-anticoagulation-khan-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparative-analysis-of-anticoagulation-khan-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/aspirin-versus-direct-oral-chi-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/aspirin-versus-direct-oral-chi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/aspirin-versus-direct-oral-chi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/aspirin-versus-direct-oral-chi-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/successful-treatment-for-a-nishihara-2024 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/successful-treatment-for-a-nishihara-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/successful-treatment-for-a-nishihara-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/successful-treatment-for-a-nishihara-2024 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-with-bivalirudin-is-asher-2026 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-with-bivalirudin-is-asher-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-with-bivalirudin-is-asher-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-with-bivalirudin-is-asher-2026 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/replantation-for-multiple-digit-kaneshiro-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/replantation-for-multiple-digit-kaneshiro-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/replantation-for-multiple-digit-kaneshiro-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/replantation-for-multiple-digit-kaneshiro-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/autophagy-and-its-role-song-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/autophagy-and-its-role-song-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/autophagy-and-its-role-song-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/autophagy-and-its-role-song-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/what-do-kayaking-and-vega-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/what-do-kayaking-and-vega-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/what-do-kayaking-and-vega-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/what-do-kayaking-and-vega-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/revascularization-of-a-circumferential-venkatramani-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/revascularization-of-a-circumferential-venkatramani-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/revascularization-of-a-circumferential-venkatramani-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/revascularization-of-a-circumferential-venkatramani-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/sulfotyrosine-mediated-recognition-of-human-calisto-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/sulfotyrosine-mediated-recognition-of-human-calisto-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/sulfotyrosine-mediated-recognition-of-human-calisto-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/sulfotyrosine-mediated-recognition-of-human-calisto-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-false-positive-rate-tran-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-false-positive-rate-tran-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-false-positive-rate-tran-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-false-positive-rate-tran-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/long-term-outcomes-of-successful-hayashi-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/long-term-outcomes-of-successful-hayashi-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/long-term-outcomes-of-successful-hayashi-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/long-term-outcomes-of-successful-hayashi-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/necrotizing-fasciitis-caused-bywith-huang-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/necrotizing-fasciitis-caused-bywith-huang-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/necrotizing-fasciitis-caused-bywith-huang-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/necrotizing-fasciitis-caused-bywith-huang-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-use-of-indocyanine-abdelwahab-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-use-of-indocyanine-abdelwahab-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-use-of-indocyanine-abdelwahab-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-use-of-indocyanine-abdelwahab-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/latest-advancements-in-autologous-chang-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/latest-advancements-in-autologous-chang-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/latest-advancements-in-autologous-chang-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/latest-advancements-in-autologous-chang-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/expansion-of-necrosis-depending-yamazaki-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/expansion-of-necrosis-depending-yamazaki-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/expansion-of-necrosis-depending-yamazaki-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/expansion-of-necrosis-depending-yamazaki-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/mitogenome-of-the-blood-sosajimxe9nez-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/mitogenome-of-the-blood-sosajimxe9nez-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/mitogenome-of-the-blood-sosajimxe9nez-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/mitogenome-of-the-blood-sosajimxe9nez-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/complete-mithochondrial-genome-of-hirudinida-liu-2017 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/complete-mithochondrial-genome-of-hirudinida-liu-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/complete-mithochondrial-genome-of-hirudinida-liu-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/complete-mithochondrial-genome-of-hirudinida-liu-2017 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/effects-of-calcium-activated-potassium-angstadt-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/effects-of-calcium-activated-potassium-angstadt-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/effects-of-calcium-activated-potassium-angstadt-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/effects-of-calcium-activated-potassium-angstadt-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/perfusion-dynamics-in-pedicled-shokri-2020 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/perfusion-dynamics-in-pedicled-shokri-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/perfusion-dynamics-in-pedicled-shokri-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/perfusion-dynamics-in-pedicled-shokri-2020 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/a-case-report-of-makhija-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/a-case-report-of-makhija-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/a-case-report-of-makhija-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/a-case-report-of-makhija-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/argatroban-anticoagulation-for-adult-geli-2021 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/argatroban-anticoagulation-for-adult-geli-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/argatroban-anticoagulation-for-adult-geli-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/argatroban-anticoagulation-for-adult-geli-2021 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/venous-thromboembolism-in-heparin-induced-thrombocytopenia 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/venous-thromboembolism-in-heparin-induced-thrombocytopenia 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/venous-thromboembolism-in-heparin-induced-thrombocytopenia 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/venous-thromboembolism-in-heparin-induced-thrombocytopenia 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/cardiac-surgery-with-cardiopulmonary-bypass-aouifi-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/cardiac-surgery-with-cardiopulmonary-bypass-aouifi-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/cardiac-surgery-with-cardiopulmonary-bypass-aouifi-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/cardiac-surgery-with-cardiopulmonary-bypass-aouifi-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/management-of-the-cleft-lip-sykes-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/management-of-the-cleft-lip-sykes-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/management-of-the-cleft-lip-sykes-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/management-of-the-cleft-lip-sykes-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/effects-of-methanol-on-expression-kim-2001 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/effects-of-methanol-on-expression-kim-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/effects-of-methanol-on-expression-kim-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/effects-of-methanol-on-expression-kim-2001 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/secondary-surgery-after-digit-replantation-wang-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/secondary-surgery-after-digit-replantation-wang-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/secondary-surgery-after-digit-replantation-wang-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/secondary-surgery-after-digit-replantation-wang-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/modern-treatment-of-pulmonary-embolism-goldhaber-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/modern-treatment-of-pulmonary-embolism-goldhaber-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/modern-treatment-of-pulmonary-embolism-goldhaber-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/modern-treatment-of-pulmonary-embolism-goldhaber-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/indications-and-surgical-techniques-for-kaplan-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/indications-and-surgical-techniques-for-kaplan-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/indications-and-surgical-techniques-for-kaplan-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/indications-and-surgical-techniques-for-kaplan-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/skeletal-fixation-in-digital-replantation-sud-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/skeletal-fixation-in-digital-replantation-sud-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/skeletal-fixation-in-digital-replantation-sud-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/skeletal-fixation-in-digital-replantation-sud-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/the-timing-of-neovascularization-in-han-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/the-timing-of-neovascularization-in-han-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/the-timing-of-neovascularization-in-han-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/the-timing-of-neovascularization-in-han-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/reconstruction-of-an-amputated-fingertip-sakai-2002 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/reconstruction-of-an-amputated-fingertip-sakai-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/reconstruction-of-an-amputated-fingertip-sakai-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/reconstruction-of-an-amputated-fingertip-sakai-2002 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/combination-platelet-glycoprotein-iib-iiia-receptor-pinto 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/combination-platelet-glycoprotein-iib-iiia-receptor-pinto 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/combination-platelet-glycoprotein-iib-iiia-receptor-pinto 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/combination-platelet-glycoprotein-iib-iiia-receptor-pinto 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-with-bivalirudin-during-cardiopulmonary-va 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-with-bivalirudin-during-cardiopulmonary-va 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-with-bivalirudin-during-cardiopulmonary-va 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-with-bivalirudin-during-cardiopulmonary-va 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/aeromonas-spp-and-traveler-s-diarrhea-vila-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/aeromonas-spp-and-traveler-s-diarrhea-vila-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/aeromonas-spp-and-traveler-s-diarrhea-vila-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/aeromonas-spp-and-traveler-s-diarrhea-vila-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-thrombocytopenia-pathophysiology-and-new-h 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-thrombocytopenia-pathophysiology-and-new-h 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-thrombocytopenia-pathophysiology-and-new-h 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-thrombocytopenia-pathophysiology-and-new-h 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/comparing-a-mechanical-device-with-hartig-2003 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/comparing-a-mechanical-device-with-hartig-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/comparing-a-mechanical-device-with-hartig-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/comparing-a-mechanical-device-with-hartig-2003 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/fingertip-replantation-using-the-subdermal-lin-2004 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/fingertip-replantation-using-the-subdermal-lin-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/fingertip-replantation-using-the-subdermal-lin-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/fingertip-replantation-using-the-subdermal-lin-2004 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/recombinant-hirudin-enhances-cardiac-output-jormalainen-20 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/recombinant-hirudin-enhances-cardiac-output-jormalainen-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/recombinant-hirudin-enhances-cardiac-output-jormalainen-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/recombinant-hirudin-enhances-cardiac-output-jormalainen-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/nonmicrosurgical-replantation-using-a-subcutaneous-muneuch 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/nonmicrosurgical-replantation-using-a-subcutaneous-muneuch 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/nonmicrosurgical-replantation-using-a-subcutaneous-muneuch 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/nonmicrosurgical-replantation-using-a-subcutaneous-muneuch 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/anticoagulation-management-and-cardiac-surgery-riess-2005 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/anticoagulation-management-and-cardiac-surgery-riess-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/anticoagulation-management-and-cardiac-surgery-riess-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/anticoagulation-management-and-cardiac-surgery-riess-2005 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/conscious-cardiac-surgery-with-cardiopulmonary-chakravarth 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/conscious-cardiac-surgery-with-cardiopulmonary-chakravarth 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/conscious-cardiac-surgery-with-cardiopulmonary-chakravarth 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/conscious-cardiac-surgery-with-cardiopulmonary-chakravarth 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-thrombocytopenia-in-neonates-martchenke-20 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-thrombocytopenia-in-neonates-martchenke-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-thrombocytopenia-in-neonates-martchenke-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-thrombocytopenia-in-neonates-martchenke-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/nonmicrosurgical-replantation-using-a-subcutaneous-van-nie 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/nonmicrosurgical-replantation-using-a-subcutaneous-van-nie 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/nonmicrosurgical-replantation-using-a-subcutaneous-van-nie 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/nonmicrosurgical-replantation-using-a-subcutaneous-van-nie 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/successful-recovery-after-an-overdose-yee-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/successful-recovery-after-an-overdose-yee-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/successful-recovery-after-an-overdose-yee-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/successful-recovery-after-an-overdose-yee-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/antithrombotic-therapy-in-cardiac-surgery-vincentelli-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/antithrombotic-therapy-in-cardiac-surgery-vincentelli-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/antithrombotic-therapy-in-cardiac-surgery-vincentelli-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/antithrombotic-therapy-in-cardiac-surgery-vincentelli-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/heparin-induced-thrombocytopenia-a-review-girolami-2006 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/heparin-induced-thrombocytopenia-a-review-girolami-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/heparin-induced-thrombocytopenia-a-review-girolami-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/heparin-induced-thrombocytopenia-a-review-girolami-2006 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/prevalence-and-antimicrobial-resistance-patterns-koksal-20 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/prevalence-and-antimicrobial-resistance-patterns-koksal-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/prevalence-and-antimicrobial-resistance-patterns-koksal-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/prevalence-and-antimicrobial-resistance-patterns-koksal-20 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/argatroban-in-extracorporeal-membrane-oxygenation-beiderli 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/argatroban-in-extracorporeal-membrane-oxygenation-beiderli 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/argatroban-in-extracorporeal-membrane-oxygenation-beiderli 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/argatroban-in-extracorporeal-membrane-oxygenation-beiderli 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/in-vitro-profile-and-ex-vivo-anticoagulant-wienen-2007 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/in-vitro-profile-and-ex-vivo-anticoagulant-wienen-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/in-vitro-profile-and-ex-vivo-anticoagulant-wienen-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/in-vitro-profile-and-ex-vivo-anticoagulant-wienen-2007 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/en/research/virulence-and-antibiotic-susceptibility-of-scoaris-2008 2026-03-18T00:00:00.000Z monthly 0.6 https://www.hirudotherapysociety.org/ru/research/virulence-and-antibiotic-susceptibility-of-scoaris-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/es/research/virulence-and-antibiotic-susceptibility-of-scoaris-2008 2026-03-18T00:00:00.000Z monthly 0.54 https://www.hirudotherapysociety.org/de/research/virulence-and-antibiotic-susceptibility-of-scoaris-2008 2026-03-18T00:00:00.000Z monthly 0.54